





















A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
(Physics) 









Associate Professor Jens-Christian D. Meiners, Chair 
Professor Bradford G. Orr 
Professor Duncan G. Steel 
Associate Professor Nils G. Walter 


























©     Katherine M Jordan 2008 





To Mom and Nick, 
For all of your support and encouragement. 
 ii
ACKNOWLEDGEMENTS 
It is with great honor and gratitude that I thank the people who have 
helped me so much throughout my life and without whose support the attainment 
of this degree would not have been possible.   
I would like to express my sincere gratitude towards my advisor, Professor 
Chris Meiners, for his patience and support throughout my research career.  I 
feel extremely fortunate to have had the opportunity to work with him on such an 
interesting and interdisciplinary project.   
I would also like to thank my thesis committee for all their feedback and for 
having shown such genuine interest in my work. Specifically, Professor Nils 
Walter, who was also our main collaborator on this project, provided a great deal 
of support, as well as many of the resources necessary for the completion of this 
project.  His expertise in catalytic RNA was instrumental to the conception and 
progress of this research.   
Dr. Richard Miller and Dr. Robert Thompson, in the University of Michigan 
Geriatrics and Neuroscience Departments, respectively, provided unlimited 
access to their microarray scanners, which were crucial for sample imaging and 
data acquisition. Also, Lynn Winkelmann’s instruction and advice regarding 
working with microarrays was invaluable during this stage of the research. 
The post-docs that I have had the opportunity to work with have been 
phenomenal teachers without whom I would have been truly lost.  I came into this 
project with a solid academic foundation in physics, but very little knowledge of 
molecular biology and biophysics.  Ari Gajraj, Meredith Newby and David Rueda 
provided countless hours of mentorship and wet-lab training in the early years of 
my research.  In the later years, Gerhard Blab provided many invaluable insights 
while helping to keep the project moving forwards and on track.  Words cannot 
 iii
truly express my appreciation of the hours that he spent, coding data analysis 
programs, teaching me MATLAB, and ducking from the edible projectiles that 
often pierce the air of the student office.  
Throughout the years, I have met so many wonderful and intelligent 
people at the University of Michigan whose friendships made the graduate 
experience so enjoyable over the years.  To all of my friends in the biophysics 
group, especially Hao, David, Yih-fan, Krishnan, Seth, Raj Kristin, Jeff, and Matt, 
thank you for making every semester go by faster than the last.  I don’t believe 
that I will ever understand your propensity towards drinking “icky” or why I was 
the only Meiners student who owned a pair of scissors, but I will miss seeing you 
every day.  Also, Raj and Matt, thank you for making the conferences we 
attended together exceptionally fun and unpredictable.  David, I have passed the 
tiara on to you, I am sure that you will wear it wisely.  Also, I would like to thank  
my friends in the Walter Lab (Liz, Chamaree, Mark, John, Miguel, Rebecca and 
Afi) for letting me share your lab space and time on the instruments.  Additionally, 
to my friends Heather and Craig, thank you for all of the times that we studied 
together or just hung out. 
 By far, the most memorable part of my graduate career was taking Plasma 
Theory, a class that ended up having no relevance to this dissertation, but which 
had the greatest impact on my life.  There, I met my husband, Nick, for whom I 
am grateful for so many things.  Mostly, I am thankful for your friendship, for your 
support during some of the most stressful times in graduate school, and for 
formatting this dissertation.  I look forward to living out our lives together as Dr. 
and Dr. Jordan and bickering over who gets to be the first Dr.   
Likewise, I would like to thank my mother for her support over the years.  
Mom, I have always admired your strength and courage to face and overcome 
life’s obstacles.  You have been there for me through many difficult times and I 
am truly grateful for that.  Without your encouragement and strong support, none 
of this would have been even possible.  
 Finally, I would like to thank all of the project sponsors. Funding for this 
project was provided by The National Institutes of Health (GM 65934-01), the 
 iv
NASA Fundamental Space Biology Program, the NASA Bioengineering Institute, 
and the Alfred P. Sloan Foundation.  Additionally, throughout the years, I 
received financial support from other sources, all for which I am extremely 
grateful.  Erie Scientific Company supplied materials necessary for sample 
preparation, such as the hundreds of coated microarray slides, free of charge.  
This support also included the Molecular Biology Training Grant and several 
teaching assistance-ships and grading appointments that I received from the 






TABLE OF CONTENTS 
DEDICATION ........................................................................................................ii 
ACKNOWLEDGEMENTS.....................................................................................iii 
LIST OF FIGURES............................................................................................. viii 
LIST OF TABLES ...............................................................................................xiv 
LIST OF APPENDICES.......................................................................................xv 
CHAPTER 1 INTRODUCTION............................................................................. 1 
1.1 Biosensors for Small Molecules ................................................................. 1 
1.2 Targets of Interest ...................................................................................... 3 
1.2.1 Pathogens........................................................................................... 3 
1.2.2 Theophylline........................................................................................ 4 
1.2.3 Biological Markers of Interest in Space Flight ..................................... 5 
1.3 Biosensor Recognition Elements................................................................ 6 
1.3.1 Antibody-Based Sensor Technology................................................... 6 
1.3.2 Aptamers and Aptasensors................................................................. 7 
1.4 Thesis Outline ............................................................................................ 8 
1.4.1 Design and Characterization of Aptazyme.......................................... 8 
1.4.2 Multiplexing in a Microarray Format .................................................... 9 
CHAPTER 2 STRUCTURE AND FUNCTION OF CATALYTIC RNA ................. 10 
2.1 Catalytic RNAs ......................................................................................... 11 
2.2 RNA Aptamer ........................................................................................... 13 
2.2.1 Aptamer Selection Using SELEX ...................................................... 13 
2.2.2 HHT5 Aptamer Specific to Theophylline ........................................... 16 
2.3 RNA Aptamers as Biosensor Component ................................................ 18 
CHAPTER 3 DESIGN AND PREPARATION OF OLIGONUCLEOTIDES.......... 22 
3.1 Design of RNA Oligonucleotides .............................................................. 22 
3.2 Preparation of synthetic substrate RNA oligonucleotides......................... 24 
3.3 In Vitro Transcription of HHT5 Hammerhead ........................................... 26 
3.4 DNA Primers Designed for Microarray Printing ........................................ 27 
CHAPTER 4 OPTICAL MEASUREMENT TECHNIQUES.................................. 28 
4.1 FRET as a Measurement Technique........................................................ 28 
4.2 Fluorophore Photobleaching .................................................................... 31 
4.3 TIRF Microscopy for Single-Molecule Measurements .............................. 32 
 vi
4.3.1 Single Molecule FRET Using TIRF ................................................... 33 
4.3.2 Optical Setup .................................................................................... 34 
4.3.3 Flow Cell Preparation........................................................................ 36 
4.4 Confocal Fluorescence Imaging............................................................... 37 
4.4.1 Confocal Imaging System ................................................................. 38 
4.4.2 Microarray Scanner Function ............................................................ 39 
4.5 Adapting Single-Molecule Experiments onto a DNA Microarray .............. 40 
4.5.1 Microarray Chip Design..................................................................... 41 
4.5.2 Preparation and Hybridization of Microarrays ................................... 44 
4.5.3 Controls and Calibrations.................................................................. 47 
CHAPTER 5 APTAMER CHARACTERIZATION................................................ 52 
5.1 Bulk Measurements.................................................................................. 52 
5.1.1 Steady state FRET assays................................................................ 52 
5.1.2 Radioactive cleavage assays and titrations ...................................... 57 
5.2 Single Molecule Measurements ............................................................... 61 
5.2.1 Sample Preparation .......................................................................... 61 
5.2.2 Single molecule FRET events........................................................... 61 
5.2.3 Single Molecule Measurement Results ............................................. 64 
5.3 Microarray Measurements........................................................................ 66 
5.3.1 Sample Preparation .......................................................................... 66 
5.3.2 Experimental Results ........................................................................ 66 
CHAPTER 6 OUTLOOK..................................................................................... 75 
6.1 Microfluidics for Single-Molecule Experiments ......................................... 75 
6.2 Lab-on-a-chip prototypes ......................................................................... 77 




LIST OF FIGURES 
Figure 1.1 Chemical structures of (a) theophylline and (b) caffeine, which differ 
only by a methyl group on N7............................................................ 5 
Figure 2.1. The generalized secondary structures of the four natural self-cleaving 
ribozyme motifs. The sequences and lengths of the helices may 
vary.  X represents A, U, or C. ........................................................ 12 
Figure 2.2. In the RNA self-cleavage reaction the RNA folds into a tertiary 
structure that orients the phosphate for attack by the adjacent 2’-
hydroxyl.  A simple modification of the RNA where the 2’-hydroxyl 
group is replaced with a 2’-methoxy group will prevent this RNA from 
self-cleaving. ................................................................................... 13 
Figure 2.3 Schematic showing a cis-acting construct disintegrated into a 
ribozyme and its complementary external substrate strand, or 
reporter RNA.  After cleavage of the reporter RNA, the sensor RNA 
retains its catalytic activity and is free to bind and cleave a new, 
uncut reporter RNA. ........................................................................ 17 
Figure 2.4 The hammerhead ribozyme for theophylline.  (a) The HHT5 construct.  
(b)  Details of the conformational change in Helix II.  In the absence 
of theophylline, the communication module (rounded light boxes) is 
misaligned in a base-pairing pattern that is stabilized by the 
formation of a G:U wobble pair. With theophylline bound, the 
communication module is correctly aligned (rounded light box), which 
allows formation of the catalytically active conformation. ................ 18 
Figure 2.5 Schematic showing FRET between a donor and acceptor fluorophore 
placed on either end of a catalytically active site.  Upon cleavage of 
the reporter RNA, or substrate, the FRET signal is lost................... 19 
Figure 2.6 The HHT5 reaction pathway.  The aptamer domain, Helix II, 
specifically binds to theophylline, at which point the sensor molecule 
becomes catalytically active and cleaves the substrate.  A unique 
fluorescence signal can be detected with a Cy3/Cy5 fluorophore pair.
........................................................................................................ 20 
 viii
Figure 3.1 Secondary structures and corresponding dG values predicted using 
mfold for (a) RC (b) NC (c) the DNA primer complementary to RC 
and (d) the DNA primer complementary to NC................................ 24 
Figure 4.1 (a) A simplified Jabłonski diagram for a FRET pair.  The values 
included are the excitation and emission wavelengths for a Cy3/Cy5 
FRET.  (b) Normalized absorption (blue) and emission (red) spectra 
for Cy3/Cy5.  The green area indicates the region of spectral overlap 
for FRET.  Image reproduced from Amersham Biosciences. .......... 30 
Figure 4.2 Energy transfer efficiency plot for a Cy3/Cy5 pair. Image reproduced 
from [Ame07]................................................................................... 31 
Figure 4.3  Cy3/Cy5 donor-acceptor labeled RNA substrates are bound to 
specific DNA oligonucleotides that are immobilized on a quartz 
coverslip through a biotin-streptavidin interaction.  Once the 
aptazyme binds an analyte molecule, it is catalytically and cleaves 
the substrate molecule.  Upon cleavage, FRET between a donor-
acceptor fluorophore pair breaks down, leading to a change from a 
donor to an acceptor dominated fluorescence signal.  Prism-based 
TIRF microscopy excites the donor with an evanescent light field and 
detects the fluorescence signal. ...................................................... 33 
Figure 4.4 Schematic of the TIRF microscopy set-up used for single-molecule 
studies. The setup involves prism-based total internal reflection 
excitation at 532nm on an Olympus IX71 inverted fluorescence 
microscope.  The resulting donor/acceptor emission is separated 
using a 630nm dichroic mirror (transmitting wavelengths <630nm 
and reflecting wavelengths >630nm) and one arm is spatially shifted 
so that the resulting two images will be projected side-by-side onto 
the Roper Scientific I-PentaMAX intensified CCD camera. ............. 35 
Figure 4.5 False color image of the Cy3 (left) and Cy5 (right) channels focused 
onto the imaging CCD. .................................................................... 36 
Figure 4.6 Schematic of the basic setup of a confocal imaging system utilized by 
a microarray scanner.  Light from a laser is reflected off of a 
beamsplitter, or dichroic mirror, toward the sample.  The returning 
(longer wavelength) fluorescence is allowed to pass through the 
dichroic, where it is filtered according to wavelength of interest, 
before reaching the detector element.............................................. 38 
Figure 4.7 Normalized absorption (blue) and emission (red) spectra for Cy3/Cy5 
showing excitation and emission using microarray scanner............ 40 
Figure 4.8 Cy3/Cy5 donor-acceptor labeled RNA substrates immobilized onto a 
coated glass slide through hybridization to DNA oligonucleotides that 
are printed in a microarray.  Once the aptazyme binds an analyte 
 ix
molecule, it is catalytically and cleaves the substrate molecule.  
Upon cleavage, FRET between a donor-acceptor fluorophore pair 
breaks down, leading to a change from a donor to an acceptor 
dominated fluorescence signal.  A microarray scanner using a 
confocal imaging system is used to excite the donor fluorophore and 
measure the resulting fluorescence signal. ..................................... 41 
Figure 4.9  Surface characterization profiles, provided by Erie Scientific 
Company, for standard coatings (left) and Enhanced Surface, ES, 
(right) coatings. The average roughness values of the coatings are 
given as 0.4339 nm for the standard coating and 16.2485 nm for the 
ES coating, with average heights of surface features of 5.2893 nm 
and 83.8990 nm, respectively. ........................................................ 43 
Figure 4.10 Schematic of a constellation design where arrays of the DNA 
oligonucleotides, RCm and NCm (yellow and blue circles), are 
printed in rows of increasing concentration (0.5 μg/μl, 1.5 μg/μl, 5.0 
μg/μl, and 15 μg/μl).  Green circles indicate calibration spots 
composed of a 0.5 μM mixture of RCm and NCm.  Grey circles 
indicate buffer spots. ....................................................................... 44 
Figure 4.11  Microarray flow cells.  Two microarray constellations are printed on 
each glass slide.  The constellations are surrounded by a parafilm 
channel, atop which the coverslip is placed.  The parafilm is melted 
using a soldering iron, adhering the coverslip to the slide and 
creating a flow channel for measurements in a fluid environment.  
Once fluid is introduced into the channel, the inlet and outlet are 
sealed using vacuum grease........................................................... 47 
Figure 4.12 Singly labeled DNA primers hybridized to microarray to test 
specificity and channel quality. The signals from a Cy3 singly labeled 
DNA probe in all three channels are shown in (a), (b), and (c). In (a), 
the strong signal shows highly specific hybridization of the singly 
labeled probe DNA to its respective printed spots. (b) No excitation 
of the Cy3 fluorophore in the Cy5 channel.  (c) The extent of signal 
bleed-through of the Cy3 fluorophore in the FRET channel resulting 
from the spectral overlap seen in Figure 4.7. The signals from a Cy5 
singly labeled DNA probe in all three channels are shown in (d), (e), 
and (f). In (d), there is no signal in the Cy3 channel. The strong 
signal in (e) shows highly specific hybridization of the singly labeled 
probe DNA to its respective printed spots. (f) The extent of signal 
bleed-through of the Cy5 fluorophore in the FRET channel. ........... 50 
Figure 4.13 Singly (top) and doubly (bottom) labeled NC RNA hybridized onto a 
microarray chip to test hybridization quality as well as the three 
measurement channels: Cy3 (a) & (d), Cy5 (b) & (e), and FRET (c) & 
(f)..................................................................................................... 51 
 x
Figure 5.1 Steady state fluorescence time trace for a cleavage experiment.  
Initially, only 50 nM RC and 50 nM biotinolated pRC are present in 
50 mM TRIS-HCl, pH 7.5, 10 mM MgCl2 and the fluorescence is 
constant.  At t = 75 sec (a), 150 nM HHT5 solution is introduced into 
the system and background cleavage of the substrate is observed.  
At approximately t = 300 sec (b) 1.5 mM theophylline is introduced 
into the system. ............................................................................... 53 
Figure 5.2 Steady state FRET assay data showing the FRET ratio as a function 
of time for the doubly-labeled RC substrate + HHT5 complex.  This is 
the background cleavage. ............................................................... 54 
Figure 5.3 Steady state FRET assay data showing the FRET ratio as a function 
of time for the doubly-labeled RC substrate + HHT5 complex upon 
the addition of 50 μM theophylline.  The FRET decay is due to the 
cleavage of the RC substrate and is slower than the decay due to 
photobleaching and background catalytic activity. .......................... 55 
Figure 5.4 Steady state FRET assay data showing the FRET ratio as a function 
of time for the doubly-labeled RC substrate + HHT5 complex upon 
the addition of 1.5 mM theophylline.  The FRET decay is due to the 
cleavage of the RC substrate and is slower than the decay observed 
for the complex in the presence of 50 μM theophylline. .................. 56 
Figure 5.5 The measured rates of decay at various theophylline concentrations.  
A faster rate of decay is observed in the presence of theophylline. 56 
Figure 5.6 Results of a radioactive cleavage assay, showing (a) the background 
cleavage of the HHT5 ribozyme and (b) the enhanced cleavage due 
to the presence of 10 mM theophylline............................................ 58 
Figure 5.7 Radioactive cleavage assay results showing an enhancement of the 
catalytic activity of the HHT5 ribozyme in the presence of 0.1 mM 
theophylline.  The cleavage rates found for 0.0mM and 0.1mM 
theophylline are kobs = 0.01 min-1 and kobs = 0.03 min-1, respectively.
........................................................................................................ 58 
Figure 5.8 Magnesium titration showing an increase in the rate of cleavage of the 
HHT5 ribozyme with magnesium concentration. ............................. 60 
Figure 5.9 Theophylline titration data showing an increase in the rate of cleavage 
of the HHT5 ribozyme with magnesium concentration. ................... 60 
Figure 5.10 A typical single-molecule FRET event. The donor fluorophore 
transfers energy to the acceptor fluorophore for approximately t = 
750 sec, at which point the acceptor disappears either due to 
photobleaching or cleavage of the RNA substrate molecule.  At 
 xi
approximately t = 1400 sec, the donor fluorophore disappears in a 
single step, indicating detection of a single molecule. ..................... 62 
Figure 5.11 A single-molecule event where the acceptor fluorophore disappears 
in a single step at t = 350 sec.  FRET between fluorophores on the 
same molecule cannot be conclusively asserted in this case.......... 63 
Figure 5.12 A single-molecule event where the donor fluorophore does not 
efficiently transfer energy to the acceptor fluorophore.  At t = 150 
sec, the donor undergoes photobleaching. ..................................... 63 
Figure 5.13 A single-molecule event which indicates conformational changes of 
the RNA complex in solution.  As the complex undergoes molecular 
dynamics, the locations of the donor and acceptor fluorophores 
change, also changing the FRET efficiency. ................................... 64 
Figure 5.14 Single molecule cleavage event data to determine the 
photobleaching rate using cleavable (RC) substrate.  Full frame data 
taken at 10.12 fps shows the fluorophore exposure rate must be 
decreased. ...................................................................................... 65 
Figure 5.15 Single molecule cleavage event data to determine the 
photobleaching rate using cleavable (RC) substrate.  Data taken at 
10.12 fps with a 0.192 exposure shows photobleaching and 
background cleavage to be slower than the expected theophylline-
enhanced cleavage based on cleavage assay results. ................... 65 
Figure 5.16 Microarray data showing the Cy3 and Cy5 signal over time for the 
RC substrate hybridized to the spots of (a) 0.5 μg/μl, (b) 1.5 μg/μl, (c) 
5.0 μg/μl, (d) 15.0 μg/μl, mRC primer.  An increase in the Cy3 signal 
is observed, corresponding to the decrease in the Cy5 channel, and 
indicating the occurrence of a FRET event.  The signal intensities 
slightly increase with primer concentration indicating that the 
saturation level for hybridization has not been reached. ................. 68 
Figure 5.17 Fluorescence signal intensity over time, measured in the Cy3 
(green), Cy5 (red), and FRET (blue) channels.  The Cy5 signal 
decay is accompanied by a slight increase in the Cy5 signal.  
However, the signal in the FRET channel is constant and can be 
attributed to the expected 10% bleed-through of the Cy3 signal. .... 69 
Figure 5.18 The average FRET ratio as a function of time calculated for 
hybridized cleavable RNA incubated with HHT5 and 10mM 
theophylline. A cleavage rate of kobs = 1.6x10-3 ± 0.2x10-3 s-1 is 
calculated from the single-exponential fit. ....................................... 70 
Figure 5.19 The average FRET ratio as a function of time calculated for 
hybridized cleavable RNA.  As a control, HHT5 is incubated with 
 xii
10mM caffeine and a cleavage rate of kobs = 1.1x10-3 ± 0.1x10-3 s-1 is 
calculated. ....................................................................................... 70 
Figure 5.20 The FRET ratio as a function of time calculated based on one spot of 
hybridized cleavable RNA.  HHT5 is incubated with 1mM 
theophylline and a cleavage rate of kobs = 1.3 x10-3 ± 0.4 x10-3 s-1 is 
calculated. ....................................................................................... 71 
Figure 5.21 The FRET ratio as a function of time calculated based on one spot of 
hybridized cleavable RNA.  HHT5 is incubated with 1mM caffeine 
and a cleavage rate of kobs = 0.8x10-3 ± 0.3 x10-3 s-1 is calculated. . 71 
Figure 5.22 The average FRET ratio as a function of time calculated for 
hybridized non-cleavable RNA incubated with HHT5 and 10mM 
theophylline.  No change in the FRET ratio is observed.................. 73 
Figure 5.23 The average FRET ratio as a function of time calculated for 
hybridized cleavable RNA incubated only with HHT5.  No change in 
the FRET ratio is observed.............................................................. 73 
Figure 6.1  Microfabricated flow channels and pneumatically actuated valves. (a) 
Overview of a device with four supply and one exit channel 
converging in a reaction/detection area in the middle of the chip. Two 
pressure lines control the flow in each of the supply channels 
through a thin membrane. (b) Shows a close-up of an open valve, 
i.e., the intersection between pressure line and supply channel. In 
(c), the control line is pressurized and pinches the flow in the supply 
line off; the valve is closed. (d) Shows the assembled and packaged 
chip together with the external reagent delivery and pressure control 
system............................................................................................. 76 
Figure 6.2 (a) Topologic structure for microfluidic mixing. Two different solutions 
are combined in a T-junction. The fluid flow is repeatedly split, 
rotated, and recombined as indicated by the arrows. (b) Schematic 
cross-section of an assembled mixing chip. The two principal 
elastomer layers are fused together and anchored with a third 
elastomer layer on a glass cover slip. The chip is embedded in a 
block of epoxy resin for additional mechanical stability; steel tubes 
provide the inlets and outlet. (c) Mixing of two fluorescently labeled 
protein solutions in a six-stage mixer at different flow rates.  Figure 
reproduced with permission [Che04b]. ............................................ 77 
 
 xiii
LIST OF TABLES  
Table 2.1 Examples of targets with known aptamers and their respective KD 
values (n.r. = not reported).  Compiled from various sources. [Ber01, 
Fei96, Fer04, Fis07, Lor94, Pan05, Sto07, Wil99] .......................... 15 
Table 3.1 dG values for sequences. ................................................................... 23 
Table 3.2 All oligonucleotide sequences used in various experiments. .............. 26 
Table A.1 Various interaction conditions tested to generate two suitable RNA 
sequences, A and B.  The sequences and their primers must not 
dimerize or cross-hybridize and show appropriate binding 
specificities.  “+” implies a non-binding spacer written as QQQ QQQ 
QQQ QQQ QQQ QQQ QQQ QQQ QQQ QQQ. ............................. 80 





LIST OF APPENDICES 
APPENDIX A MFOLD SECONDARY STRUCTURE PREDICTION................... 80 
A.1 RNA Sequence Generation Technique.................................................... 80 
A.2 Scripts and Functions .............................................................................. 84 
A.2.1 Evolutionary Sequence Script evoltest.m ......................................... 84 
A.2.2 Function generate_sequences.m ..................................................... 88 
A.2.3 Script: analyze_data ......................................................................... 89 
A.2.4 Sequence Generator for Manual mfold Testing ................................ 90 
 
APPENDIX B LABORATORY PROTOCOLS ..................................................... 91 
B.1 Labeling Modified RNA ............................................................................ 91 
B.1.1 RNA Deprotection............................................................................. 91 
B.1.2 15% Polyacrylamide Gel Electrophoresis ......................................... 91 
B.1.3 RNA Extraction Post Gel Purification................................................ 92 
B.1.4 HPLC Purification ............................................................................. 92 
B.1.5 Removal of Triethylamine from HPLC Purification Pre Labeling....... 94 
B.1.6 Cy3 Labeling Post HPLC Purification ............................................... 94 
B.2 Modified DNA Protocol............................................................................. 94 
B.3 In Vitro Transcription Protocol for HHT5 Hammerhead............................ 95 
B.4 Sample Preparation for Single-Molecule TIR-FRET Experiments............ 96 
B.5 Spectrophotometer Calculations.............................................................. 97 
B.6 Preparation of Slides for Microarray Printing ........................................... 97 
B.7 Microarray Sample Preparation Protocol ................................................. 98 
B.8 Spin Coating a 30μm Layer of PDMS Onto a Coverslip......................... 100 




The ability to identify and quantify the concentrations of drugs, second 
messengers, hormones, proteins and pathogens is of fundamental biomedical 
importance.  Although DNA microarray chips are revolutionizing biology by 
expanding our analyses from single-gene to genome-wide gene expression, 
analogous methods for the simultaneous study of the metabolome and proteome 
are not yet available.  In addition, rapid monitoring of cellular events such as 
second messenger synthesis and hormone secretion in single cells is key to 
understanding cellular organization in higher organisms, yet is still not fully 
accomplished.  Finally, early pathogen detection is of increasing urgency in 
clinical diagnosis and bio-defense in the face of newly emerging infectious 
diseases.  For these applications, new biosensor technologies are needed. 
1.1 Biosensors for Small Molecules 
A biosensor is described as an analytical device that uses a biodetector, 
such as enzymes, antibodies, nucleic acids, microorganisms, or tissues to 
specifically detect a target analyte of interest without the need for complex 
specimen processing [Set94].  Traditionally, the biosensor has three parts: the 
sensitive biological element, a physiochemical detector element, and the 
transducer in between which associates both components [IUP07].  Ideally, a 
biosensor is extremely sensitive and highly specific for the target of interest, with 
the capability for specificity based on chirality.  Additionally, its design is 
adaptable to a wide range of target analytes, as well as compact, rugged, and 
devised to consume minimal resources [Sch01a]. 
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Biosensors were first developed for clinical applications and the medical 
applications for these biosensors are numerous.  They include drug discovery 
and design, the monitoring of drug delivery in time, and the detection and 
quantification of small molecules.  The first such device was an enzyme 
electrode developed by Leland C. Clark in 1962 and the first biosensor system to 
come to market was for glucose in 1975 [Set94].  More biosensor instruments 
were launched in the late 1980’s, beginning a surge in the development of 
biosensor products designed for the diagnostics market and sold worldwide.  
In the last decade, there has been great interest in the development of 
efficient and portable pathogen detection biosensors for biosecurity [Fis07] 
stemming from the intentional dissemination of Bacillus anthacis spores by 
contaminated U.S. Postal Service mail in the fall of 2001.  This not only resulted 
in panic in the general public, but also a deeper awareness of the importance of 
rapidly and accurately detecting such events.  Great strides have been made in 
the environmental surveillance of potential biologically threatening agents 
[Lim05], however, technological developments are still needed for fabrication of 
efficient, portable, fieldable, and highly robust sensors [Fis07]. 
The limitations of biosensors can be extended far beyond their current 
uses in medicine and biosecurity to use in space flight to monitor the health 
status of the crew.  A biosensor can potentially be used to measure the amount 
of radiation damage that cellular DNA has suffered by sensing 8-hydroxy-
2’deoxyguanosine, a biomarker for free-radical induced damage to DNA, or to 
monitor a suite of cytokines to obtain a near real-time assessment of the status of 
the immune system of an astronaut. A biosensor is also of interest for the search 
of life on planetary systems, as it may detect trace amounts of signature 
molecules for organic life, such as certain sets of amino acids, with high 
sensitivity and specificity. 
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1.2 Targets of Interest 
There are many sensitive biological elements, or target analytes, to 
choose from, including amino acids, antibodies, cofactors, nucleotides and 
nucleobases, pathogens, and small organic or inorganic compounds. 
1.2.1 Pathogens 
1.2.1.1 Bacillus anthracis 
Increasing attention and resources have been focused on the rapid 
detection and characterization of pathogens in the past decade.  B. anthracis are 
soil-born bacteria endemic to several regions of the US and around the world, 
with at least 89 reported B. anthracis strains, most of which to not poses any 
threat.  However, the Ames is most virulent strain, used in the postal attack, and 
the Vollum strain has been deemed most suitable for use in bioweapons [Fis07].  
The bacteria reside dormant in the soil as endospores, surviving for long periods 
of time under varying environmental conditions.  Once consumed or inhaled, the 
bacteria rapidly multiply, ultimately causing the death of the host.   
Various biosensing techniques for B. anthracis have been developed, 
including antibody affinity reagents, calorimetric assays and DNA aptamers 
[Bru99, Zhe02].  Bruno and Kiel first described a biosensor with the ability to bind 
to the anthrax spore target with a wide dynamic range from <10 to >6 x 106 
anthrax spores.  More recently, Yang and coworkers developed a detection 
assay capable of detecting ~4 x 107 spores, with a dynamic range of 4 x 104 to 
4 x 107 spores [Zhe02].   
1.2.1.2 Influenza Virus 
Commonly called the flu, influenza is caused by an RNA-based virus that 
belongs to the Orthomyxoviridae family and can easily be transmitted via bodily 
fluids or through the air from infected individuals.  Influenza has resulted in 
widespread disease and considerable fatalities, with three pandemics occurring 
in the last century.  The deadly avian influenza has recently become a great 
concern, though it has only resulted in ~100 fatalities and is not easily transmitted 
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to humans [Per05].  However, mutation of the H5N1 strain could result in a strain 
that is more easily transmittable to, and among, humans. 
Hemagglutinin (HA) is one of the main glycoproteins present on the 
surface of the influenza virus envelope.  It facilitates viral entry by binding to sialic 
acid-modified receptors on host cells.  HA is capable of undergoing mutations 
from generation to generation, making the development if high affinity reagents 
and the generation of vaccines against the virus very difficult [Fis07].  Sensing 
techniques have been developed that can not only detect HA, but can also be 
modified as to also inhibit the HA-mediated membrane fusion process, which 
greatly underscores their potential application as an anti-influenza therapeutic 
[Gop06a, Gop06b]. 
Methods most widely used to identify influenza subtypes require 
approximately four days.  Rowlen and coworkers from the University of Colorado 
at Boulder and the Centers for Disease Control and Prevention (CDC) developed 
a microchip-based test, termed the FluChip, that can distinguish among 72 
influenza strains, including the H5N1 avian influenza strain, in less than 12 hours 
[Tow06], allowing health professionals to more quickly respond to an infection 
and potentially reduce the spread of the disease. 
1.2.2 Theophylline 
The target for the proposed biosensor is the small organic compound, 
theophylline (Figure 1.1(a)), a methylxanthine that acts as a bronchodilator.  
Thus, theophylline has been commonly prescribed as a long-term treatment of 
asthma, bronchitis and emphysema [Hen83].  Because theophylline has a very 
narrow therapeutic range, serum levels must be monitored closely to avoid 
toxicity.  Optimal benefits occur at serum concentrations greater than 55 μM, 
while the frequency and severity of toxic effects, such as dose dumping when 
taken with fatty meals, increase above 110 μM [Hen85].  Therefore, the 
stabilization of hyperreactive airways is most likely when a 55 -110 μM 
therapeutic range is maintained around-the-clock [Hen85].   
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Figure 1.1 Chemical structures of (a) theophylline and (b) caffeine, which differ only by a methyl 
group on N7. 
The development of HPLC based assays and, more recently, of antibody-
based fluorescence-polarization immunoassays such as the AxSYM theophylline 
II assay [Abb07] made the necessary therapeutic drug monitoring in serum 
possible.  However, theophylline detection is non-trivial due to its similar 
molecular structure and physicochemistry to other methylxanthines, such as 
theobromine and caffeine (Figure 1.1(b)), which carries a single additional methyl 
group on N7 of the purine ring.  Theophylline, caffeine and theobromine are all 
found in teas, colas and other caffeinated food products, though in varying 
amounts.  As caffeine may commonly occur in the blood stream at 
concentrations of about 50 – 350 μM [Foo98], theophylline detection is 
notoriously difficult.  Therefore, a novel, more specific biosensor for theophylline 
is therefore highly desirable and can be evaluated compared to existing detection 
technologies. 
1.2.3 Biological Markers of Interest in Space Flight 
1.2.3.1 8-hydroxyl-2’-deoxyguanosine 
Some of the largest risks of long-duration human space flights are 
associated with the acute and long-term effects of radiation exposure.  The low to 
moderate doses of ionizing radiation typically absorbed during space flight 
damage cellular DNA by creating reactive oxygen species [Rob94].  These free 
radicals are extremely reactive and can damage the DNA in a number of ways, 
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such as creating or breaking bonds in the phosphate backbone of the DNA, or by 
modifying the purine or pyrimidine bases. 
8-hydroxy-2’-deoxyguanosine is a product of the reaction between 
reactive oxygen species and the guanosine base in DNA that is generally 
considered a reliable biomarker for reactive-oxygen-species mediated DNA 
damage [Sch01b]. As current assay techniques for 8-hydroxy-2’-deoxyguanosine 
cannot be carried out in space flight due too their cumbersome nature [Ans00, 
Hua01], biosensor technology can be applied to this end.   
1.2.3.2 Cytokines 
Monitoring the immune system during long-duration space flight is 
necessary, as data suggests that some factors involved in immunologic functions 
may be altered during space flight [Hun94], and continuous monitoring of these 
changes is necessary to determine if pharmacological or other countermeasures 
must be used to maintain a healthy immune system. Also, continuous monitoring 
of the immune system can provide an early indication of a developing health 
problem, such as an infection or inflammation.  
Cytokines, such as interleukins and interferons, modulate the immune 
response, and can provide a great deal of information about the status of the 
immune system.  These substances, however, have very low concentrations in 
the human body, and their detection and quantification is non-trivial.  As the 
analysis of blood samples of astronauts with respect to these compounds is 
usually done upon return to earth, this facilitates the need for biosensors that can 
detect a suit of cytokines from a very small sample volume. Such a device would 
provide for easy monitoring of the immune status of astronauts during long space 
flights. 
1.3 Biosensor Recognition Elements 
1.3.1 Antibody-Based Sensor Technology 
The traditional recognition elements for detection of analytes in the sub-
nanomolar concentration region are antibodies, in combination with optical or 
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electrochemical sensors.  These immunosensors register the concentration of an 
analyte in real time without auxiliary reagents.  Currently, antibodies are used for 
small-sized devices to target a single defined analyte or for the simultaneous 
detection of a very large number of different proteins with protein chips for 
proteomics [Sch01a]. Most immunosensors are based on enzyme-linked 
immunosorbent assay (ELISA) principles, with sensor-immobilized antibodies or 
antigens where the enzyme label such as peroxidase, alkaline phosphatase or 
glucose oxidase, is detected by measuring the produced iodine [Ris97], p-
aminophenol [Duc97] or hydrogen peroxide [Ben00].  
Reliable measurements using antibodies are only possible if the antibody 
layer is renewed after each measurement or if an indirect competitive assay is 
applied with a stable derivative of the antigen bound to the sensor surface 
[Bie94].  Antibodies are also limited, by their structural robustness under varying 
temperatures and humidity levels [Fis07]. 
1.3.2 Aptamers and Aptasensors 
It is widely known that RNA can carry genetic information encoded in its 
linear sequence. Due to the high thermodynamic stability of the secondary 
structure (Watson-Crick base pairing), RNA provides for a stable scaffold that 
allows it to acquire diverse tertiary structures, or aptamers. These aptamers can 
have catalytic functions and can recognize specific analytes with extremely high 
specificity and sensitivity, in some cases even surpassing those of antibodies 
[Osu02].   
Although aptamers were only discovered in 1990, they are already being 
developed as analytical agents [Tom05] and for clinical treatments [Cer02].  They 
have also been proposed as alternatives to antibodies for biosensing applications 
[Kir04, Pot98, McC03, Sil03, Sek02].  Aptamers often retain their ligand-binding 
properties when incorporated into larger RNA, allowing for the engineering of 
allosteric ribozymes comprised of a specific aptamer motif, hammerhead catalytic 
core, and a structurally responsive communication domain between the 
two [Koi99, Sou99a Sou99b, Sou00, Sou01]. 
 7
There are several advantages of using RNA molecules as components of 
biosensors.  The first advantage is the simplicity of generating high quality 
molecular recognition elements for analytes by implementing the systematic 
evolution of ligands by exponential enrichment (SELEX) [Klu94].  Additionally, the 
ease of designing aptazymes from the aptamer, ribozyme, and a substrate strand 
[Bre97, Bre02, Sek02] and the relative ease of the use of optical techniques, 
such as TIRF microscopy [Zhu02] for single-molecule detection.   
1.4 Thesis Outline 
1.4.1 Design and Characterization of Aptazyme 
As further described in Chapter 2, in vitro-evolved RNA molecules, or 
aptamers, act as receptors that recognize a wide variety of target molecules with 
specificity higher than that of antibodies.  An aptamer of high affinity for 
theophylline is chemically synthesized and coupled through a communication 
domain to an RNA enzyme, generating an aptazyme that is bound to an 
immobilized fluorescent substrate.  The design and synthesis of the aptamer, 
aptazyme and other oligonucleotides used is discussed in Chapter 3. 
Upon analyte binding, the aptazyme becomes activated and cleaves 
surface immobilized RNA substrate molecules between a site-specifically 
attached Cy3/Cy5 donor-acceptor pair.  As a result, the products, which 
individually bind only weakly to the aptazyme, dissociate and FRET between the 
fluorophores breaks down; thus, the signal changes from one that is acceptor 
dominated to one that is donor dominated.  The aptazyme is then free to bind 
and cleave other immobilized substrates.  This amplified signal change is easily 
detected by the various optical methods described in Chapter 4, including prism 
based TIRF or confocal microscopy.  Fluorescence techniques are used to detect 
this signal with high sensitivity.   
Chapter 5 includes characterization of the RNA using bulk method 
techniques, single molecule studies and microarray techniques. 
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1.4.2 Multiplexing in a Microarray Format 
Experimentation in solution, as well as on the single-molecule level, shows 
the feasibility of the system for biosensing.  Adapting microarray technologies 
allows for compact optical detection methodology and grants us the adaptability 
to detect multiple targets on a single chip. 
DNA microarrays are typically used for rapid detection of gene mutations 
[Shu97], as well as for gene expression [DeR96, DeS98, Sch96], though their 
potential applications in biosensor technology have become more apparent in 
recent years [Ben05, Che06].  For example, McCauley and coworkers utilized 
immobilized DNA and RNA aptamers to develop a biosensor for muliplex 
analysis of protein analytes [McC03].  More recently, Collet and coworkers 
immobilized biotinylated RNA aptamers onto streptavidin coated slides in a 




STRUCTURE AND FUNCTION OF CATALYTIC RNA 
DNA and RNA are typically described as carriers of genetic information, 
where DNA stores the genetic information until recruiting specific protein 
enzymes to guide its own replication as well as transcription to yield RNA.  In 
turn, RNA directs the biosynthesis of proteins through translation.  However, in 
spite of more than half a century of study, new roles for DNA and RNA are still 
being discovered.  These discoveries subsequently lead to new ways in which 
nucleic acids can be manipulated to study their biological function, physical 
properties, or use as a material to create devices and surface patterns [Fei04].  
DNA is a double stranded helix which is stabilized via Watson-Crick 
pairing, while RNA is single stranded.  However, most biologically active RNAs 
including transfer RNA (tRNA), ribosomal RNA (rRNA), small nuclear RNAs 
(snRNAs) and other non-coding RNAs (such as the signal recognition particle, or 
SRP, RNAs) are highly structured in that they are extensively base paired to form 
short regions of double stranded helices formed by the same Watson-Crick base 
pairing as in DNA.  The high thermodynamic stability of these secondary 
structures provides for a stable scaffold that allows it to acquire diverse tertiary 
structures [Ges99].  These structures are not limited to long double-stranded 
helices, as in DNA, but rather collections of short helices packed together into 
structures analogous to proteins. 
This information has led to the discovery that RNA can catalyze chemical 
reactions, like enzymes, based on its ability to fold into complex three-
dimensional structures [Dou02, Ges99].  In 1986, Gilbert coined the phrase “The 
RNA World”, in reference to the hypothesis that RNA could have once combined 
the roles of genetic material and biocatalyst in living systems [Gil86].  During this 
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hypothetical evolutionary stage, proteins were not yet engaged in biochemical 
reactions and RNA solely carried out both the information storage task of genetic 
information and the full range of catalytic roles necessary in a very primitive self-
replicating system. Gilbert pointed out that neither DNA, nor proteins, was 
required in such a primitive system if RNA could perform as a catalyst [Gil86].  
While protein enzymes are now the dominate catalysts in cells, RNA still contains 
the necessary elements to aid catalysis in an effective manner.  For example, in 
translation, genetic information is coded and decoded via RNA secondary 
structure interactions that allow formation of intricate tertiary structures that 
contain catalytically active components of the gene processing machinery 
[Moo02].  While forming discrete secondary and tertiary structures, RNA can also 
undergo substantial conformational changes in the course of a reaction pathway.  
Therefore, numerous structural and biochemical studies of RNA enzymes or 
ribozymes have revealed that catalysis is inherently coupled to their three-
dimensional structure and conformational dynamics [Tin05]. 
2.1 Catalytic RNAs 
The belief that all known enzymes were proteins was demolished over two 
decades ago with the discovery that some RNA can exhibit catalytic activity or 
behave in an enzyme-like manner to catalyze a reaction [Cec81, Cec92].  The 
discovery of these fairly large catalytic RNAs, or ribozymes, fuelled the growth of 
the RNA field.   
Although some of these reactions are facilitated by proteins in vivo, their 
reactions can be simulated in vitro without the aid of proteins, supporting the view 
that the RNA itself can do the job. With the exception of RNase P RNA and the 
ribosome, the RNAs undergo an intramolecular, or in cis, transesterification in 
these transformations [Gil86]. These reactions are sequence specific, and more 
importantly, occur with rates orders of magnitude faster than expected from the 
background reactivity of RNA. Thus there must be a catalytic element involved, 
and therefore these active RNAs are called ribozymes, in analogy to the classical 
protein enzymes.   
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There are four classes of naturally occurring ribozyme motifs (Figure 2.1) 
that exhibit self-cleavage [Sco07].  Each motif can accelerate the divalent-metal-
dependent cleavage of RNA via a cyclizing transesterification mechanism shown 
in Figure 2.2.  The different motifs are defined by characteristic secondary 
structure folds and by regions of conserved nucleotides and can fold into a 
defined tertiary structure that properly orients the phosphate for attack by the 
adjacent 2’-hydroxyl [Bre97, Wal98, Wil92].   
Of these four motifs, the hammerhead is the smallest, affording the 
advantageous arrangement that contains only Helix II, resulting in a complex 
where the conserved residues reside in a short domain of approximately 30 
nucleotides (nt) [Sta98].  Therefore, to study the mechanism of these ribozyme-
catalyzed reactions and their structural requirements, the ribozymes were 
redesigned for intermolecular, or in trans, reactions [Sek02]. Thus the substrate 
and ribozyme are localized on different RNA strands.  
 
 
Figure 2.1. The generalized secondary structures of the four natural self-cleaving ribozyme 




Figure 2.2. In the RNA self-cleavage reaction the RNA folds into a tertiary structure that orients 
the phosphate for attack by the adjacent 2’-hydroxyl.  A simple modification of the RNA where the 
2’-hydroxyl group is replaced with a 2’-methoxy group will prevent this RNA from self-cleaving. 
2.2 RNA Aptamer 
2.2.1 Aptamer Selection Using SELEX 
The highly repetitive nature of RNA and DNA molecules makes them 
relatively simple to synthesize and manipulate in vitro, using the SELEX 
(systematic evolution of ligands by exponential amplification) method.   This in 
vitro selection method isolates catalytic molecules from random sequence pools 
of RNA or DNA.  This approach relies on the probability that in a given pool of 
random sequences, molecules which can perform the function of interest, such 
as binding to a specific target molecule, will exist.  A rigorous mathematical 
analysis of SELEX has been recently described by Levine and Nilsen-Hamilton 
[Lev07]. 
The process begins with a large (~1015) random pool of nucleic acid 
sequences, where approximately 15 million molecules are expected to carry the 
hammerhead catalytic core, and some are expected to efficiently catalyze RNA 
cleavage [Bre97].  Each molecule in the pool is of the same length, between 40-
80 bases long, but varies in its internal sequence.  These molecules are subject 
to a negative selection by incubation in the absence of the desired target.  RNA 
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molecules that do not self-cleave are then isolated and subject to a positive 
selection.   The target of interest is attached to a solid support, such as a column 
or gel, to select molecules with sequences that promote folding into structures 
that bind to the target.  These allosterically controlled ribozymes are then RT-
PCR amplified and transcribed to produce material for a new round of selection.  
In each round of SELEX, the goal is to select the nucleic acid sequences with the 
highest affinity for the target molecule while eliminating background sequences 
that may bind to the support.   Successive rounds (typically 10-15) lead to an 
optimization of the molecule to the desired sensitivity and selectivity [Wil99].   
The molecules that emerge from in vitro selections are hence termed 
“aptamers”.  These aptamers can be selected for very high affinity and specificity, 
even chiral specificity, for targets of interest.  The affinities are often comparable 
to those observed for antibodies, with most of the calculated KD values in the low 
nanomolar to micromolar range, depending on the measuring principle [Pat97].  
Some of these targets and their respective KD values are listed in Table 2.1.   
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Table 2.1 Examples of targets with known aptamers and their respective KD values (n.r. = not 
reported).  Compiled from various sources. [Ber01, Fei96, Fer04, Fis07, Lor94, Pan05, Sto07, 
Wil99] 
Target Aptamer Type KD 
Amino acids    
RNA 330 nM  l-Arginine 
DNA 2.5 mM 
  l-Citrulline RNA 62–68 μM 
  d-Tryptophan RNA 18 μM 
  l-Valine RNA 12 mM 
Antibiotics    
  Chloramphenicol RNA 25–65 μM 
  Kanamycin A RNA ≤300 nM 
  Kanamycin B RNA 180 nM 
  Lividomycin RNA ≤300 nM 
  Neomycin RNA 100 nM 
  Streptomycin RNA n.r. 
  Tetracycline RNA 1 μM 
  Tobramycin RNA 2–3 nM 
Cofactors    
  Cyanocobalamin  (Vitamin B12) RNA 320 +/- 90 nM 
  NAD RNA 2.5 μM 
  Riboflavin RNA 1–5 μM 
 RMP-botin RNA 2 μM 
Inorganic components   
  Ni2+ RNA 0.8–29 μM 
  Zn2+ RNA 1.2 mM 
Nucleotides and nucleobases    
  Adenine RNA 10 μM 
 ATP RNA 4.8–11 μM 
  ATP/adenosine DNA 6 μM 
 Guanosine RNA 32 μM 
 7-methyl-GTP RNA ~0.5 μM 
  Xanthine RNA 3.3 μM 
Pathogens    
  Anthrax spores DNA n.r. 
  Salmonella typhi RNA 7 nM 
  Tularemia DNA n.r. 
Small organic molecules    
  Caffeine RNA 1 mM 
  Dopamine RNA 2.8 μM 
  Ricin toxin DNA 58–105 nM 
  Theophylline RNA 100 nM 
2.2.2 HHT5 Aptamer Specific to Theophylline 
Although aptamers were only discovered in 1990, they are already being 
developed as analytical agents [Tom05] and for clinical treatments [Cer02].  
Aptamers often retain their ligand-binding properties when incorporated into 
larger RNA, allowing for the engineering of allosteric ribozymes comprised of a 
specific aptamer motif, hammerhead catalytic core, and a structurally responsive 
communication domain between the two [Koi99, Sou99a Sou99b, Sou00a, 
Sou00b, Sou01].   By incorporating the aptamer motif and the communication 
domain into Helix 2 of a hammerhead ribozyme, catalytic activity becomes 
responsive to the binding of the aptamer to the target molecule [Sek02].  This 
catalytic RNA complex is sometimes described as an “aptazyme” [Nav06]. 
Breaker and coworkers have engineered such a hammerhead ribozyme to 
be activated in the presence of theophylline (Figure 1.1(a)), a bronchodilator 
commonly used for the treatment of respiratory diseases such as asthma. It is a 
member of the xanthine family and bears structural and pharmacological 
similarities to caffeine (Figure 1.1(b)) [Bre97].  Therefore, caffeine is used as an 
experimental control for this biosensor. 
 The theophylline ribozyme designed by Breaker, HHT, is 77 nucleotides 
long and cleaves intramolecularly (in cis) with a rate constant of ~0.1 min-1 in  
1 mM theophylline, which is ~100-fold faster than background cleavage in the 
absence of cognate ligand [Bre97, Bre02].  There has been significant interest in 
this aptamer and, consequently, its potential incorporation into a biosensor 
[Sou00, Zim98, Zim00].  Sekella, et al [Sek02] subsequently utilized a modified 
construct, HHT1, for the development of a fluorescence-based biosensor.  The 
original HHT cis-acting construct was disintegrated into a ribozyme and its 
complementary external substrate strand as shown in Figure 2.3.  This allows for 
efficient chemical synthesis of the substrate and the creation of a rechargeable 
biosensor, capable of multiple turnover.   
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Figure 2.3 Schematic showing a cis-acting construct disintegrated into a ribozyme and its 
complementary external substrate strand, or reporter RNA.  After cleavage of the reporter RNA, 
the sensor RNA retains its catalytic activity and is free to bind and cleave a new, uncut reporter 
RNA. 
We have redesigned the HHT1 construct with several modifications to 
improve the biosensing capabilities of the ribozyme.  The sequences of the 
substrate and the substrate-binding arms of the ribozyme were changed to those 
of a previously characterized hammerhead ribozyme [Mic00] to avoid self-
complementarities of the original substrate strand.  Additionally, an A:U base pair 
is placed downstream of the cleavage site to accelerate hammerhead ribozyme 
cleavage [Clo97], so that the detection time for biosensing is decreased.   
This modified construct is a result of several experiments that have led to 
a better understanding of the theophylline-specific aptamer-ribozyme complex, 
including the work by Sekella, et al [Sek02].  This newest generation, labeled 
HHT5, is shown in Figure 2.4(a).  A G:C pair has been removed from the hairpin 
region for some reason.  Additionally, the 3’ end has been extended with the 
sequence AUAUAUA and the GG on the 5’ end has been replaced with AUAG.  
These modifications were made so that when the ribozyme is incorporated into 
the substrate, any labels on the substrate will be a sufficient distance away from 
Guanine.  The importance of this redesign will become more apparent in Chapter 
4, as fluorescent labels are used for the detection mechanism and fluorophore 
quenching due to stacking interactions must be prevented.   
The theophylline binding reaction of this newest construct generation, 
HHT5, is shown in Figure 2.4(b).  In the absence of theophylline, the 
communication module region (indicated by rounded light boxes) is misaligned in 
a base-pairing pattern that is stabilized by the formation of a G:U wobble pair. 
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Once the aptamer binds to theophylline, the communication module is correctly 
aligned, which allows formation of the catalytically active conformation. 
 
 
Figure 2.4 The hammerhead ribozyme for theophylline.  (a) The HHT5 construct.  (b)  Details of 
the conformational change in Helix II.  In the absence of theophylline, the communication module 
(rounded light boxes) is misaligned in a base-pairing pattern that is stabilized by the formation of 
a G:U wobble pair. With theophylline bound, the communication module is correctly aligned 
(rounded light box), which allows formation of the catalytically active conformation. 
2.3 RNA Aptamers as Biosensor Component 
In recent years, the promise of aptamers as biosensing components has 
been recognized and extensive research is being done in this field.  Aptamers 
have been generated against a large range of targets and adapted for numerous 
chemical or biological sensing systems [Fis07], several of which are listed in 
Table 2.1.  For example, Bruno and Kiel derived DNA aptamers against the Stern 
strain of bacillus anthracis in 1999 [Bru99].  These aptamers were incorporated 
into an aptamer-magnetic bead-electrochemiluminescence sandwich assay as 
well as into a calorimetric assay to demonstrate binding to the target with a 
dynamic range from less than10 to >6 × 106 anthrax spores.  Extensive studies 
have also been done on the development of aptamers against the glycoproteins 
found on the surface of the influenza virus envelope.  One of these studies led to 
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the isolation of RNA aptamers against the purified HA of human A influenza 
virus, subtype H3N2 [Mis05, Gop06a, Gop06b].   
Several different techniques have been employed, including SELEX, for the 
development of aptamers with very high specificity for targets of interest.  These 
aptamers can then be incorporated into a variety of sensing platforms and 
detection assays, such as microarrays, microbead platform, nanoparticle-based 
platforms, or various electronic platforms [Fis07].  For this biosensor, we have 
incorporated various optical techniques to measure fluorescence signals due to 
fluorescence resonance energy transfer (FRET) [For48, Rue06, Vog06], which 
will be discussed in detail in Chapter 4.  In short, excitation energy of a donor 
fluorophore is transferred to the acceptor fluorophore via an induced dipole-
dipole interaction without the involvement of an intermediate photon as shown in 
Figure 2.5.  FRET will occur if the emission spectrum of the donor overlaps with 
the absorption spectrum of the acceptor.   
 
 
Figure 2.5 Schematic showing FRET between a donor and acceptor fluorophore placed on either 
end of a catalytically active site.  Upon cleavage of the reporter RNA, or substrate, the FRET 
signal is lost. 




Figure 2.6 The HHT5 reaction pathway.  The aptamer domain, Helix II, specifically binds to theophylline, at which point the sensor molecule 
becomes catalytically active and cleaves the substrate.  A unique fluorescence signal can be detected with a Cy3/Cy5 fluorophore pair.
 
 
Therefore, we have incorporated the theophylline-specific aptamer into a 
ribozyme with a complementary structurally responsive substrate domain that 
permits structural changes and allows for tethering to a solid surface for 
experimentation.  Site-specific labeling of the substrate with a Cyanine 3 donor 
fluorophore and Cyanine 5 acceptor fluorophore (Cy3/Cy5, respectively) on 
either end of the catalytically active site will allow for direct detection of target-
binding induced cleavage of the substrate RNA (Figure 2.5).  The loss of FRET 
signal due to substrate cleavage leads to a unique fluorescent signal that can be 
detected using a variety of optical techniques, such as total internal reflection 
microscopy (TIRF) or confocal fluorescence imaging, on the single molecule level 
(see Chapter 4 for further discussion).  This gives the detector its high fidelity. 
Figure 2.6 shows the reaction pathway of the RNA complex designed for 
the theophylline specific biosensor.  Upon binding to theophylline, the HHT5 
complex will rearrange and undergo substrate cleavage.  The cleavage will then 
cause disassociation of the labeled substrate reporter, allowing the fluorophores 
to proliferate, hindering FRET between them.  The 3’ end of the RNA substrate 
has been extended to allow for a “tail” region that can bind to a complementary 





DESIGN AND PREPARATION OF OLIGONUCLEOTIDES 
3.1 Design of RNA Oligonucleotides 
As previously described, the RNA substrate strand (RC) was designed 
with a region complementary to the HHT5 ribozyme and a 24 nt tail on the 3’ end.  
For structural and kinetic studies, a non-cleavable (NC) substrate analog with a 
distinguishable tail region was synthesized with the nucleotide 5’ to the cleavage 
site modified with a 2’-methoxy group to chemically block cleavage.  The detailed 
substrate cleavage mechanism has been described in Figure 2.2.  Using Michael 
Zuker’s mfold secondary structure predictor, mfold program version 3.0 [Zuk03, 
Zuk99], RNA sequences were tested for sufficient distinguishability between the 
NC and RC species as well as their complementary primers.   
To find and test possible sequences, a computational evolution method 
was implemented and the generated sequences were checked for dimerization 
(the hybridization of two identical molecules), RNA cross-hybridization (the 
hybridization of the substrates or primers to one another), and binding specificity 
(where the RNA substrate binds only to its primer).  A more detailed description 
of this process is given in Appendix A.  In short, 1000 random starter sequences 
of 23 bases long were generated.  Each random sequence, and its 
corresponding 19 nt primers, were tested for dimerization, cross-hybridization, 
and binding specificity.  The sequences then underwent twenty iterations of 
mutation and recombination using a simple crossover technique before the “best” 
sequences were chosen from the final results.  These sequences were then 
tested for secondary structure at 22 ˚C with a 0.6 mM Na concentration.  This 
process was repeated several times before two new sequences were eventually 
chosen for the RC and NC RNA substrate.  The secondary structures for these 
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sequences and corresponding DNA primers, pRC and pNC, are shown in Figure 
3.1 and the dG values for these sequences and each test case are given in Table 
3.1, showing a low thermodynamic stability of each non-ideal case.  The 
secondary structures and dG values for the various test cases are given in 
Appendix A.   
All oligonucleotides were thus designed based on these sequences.  For 
simplicity in referencing, the oligonucleotides used and their respective 
sequences are listed in Table 3.2. 
 











RC sequence -1.8 RC + RC -6.2 RC + pNC -1.9 
NC sequence -2.8 NC + NC -5.5 NC + pRC -3.57 
pRC (primer) -1.2 pRC + pRC -2.6 RC + NC -5.3 





Figure 3.1 Secondary structures and corresponding dG values predicted using mfold for (a) RC 
(b) NC (c) the DNA primer complementary to RC and (d) the DNA primer complementary to NC. 
3.2 Preparation of synthetic substrate RNA oligonucleotides 
RNA oligonucleotides were purchased from the Y. M. Keck Foundation 
Biotechnology Resource Laboratory at the Yale University School of Medicine. 
The following RNA substrate and primer sequences were purchased:  cleavable 
RNA substrate 5’- [Cy5] UAC CCG UCU GUU GUA [dt_NH2] UC AUU CUA UCC 
UCC UUU CAC UUA GU -3’ and its corresponding primer 5’- ACT AAG TGA 
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AAG GAG GAT A -3’ and non-cleavable RNA substrate  5’- [Cy5] AUC CCG U [C 
2’-methoxy] U GUU GUA [dT_NH2] UC CCA AAA AAA AAA AGC CGU AAA CU 
-3’ and its corresponding primer 5’- AGT TTA CGG CTT TTT TTT T -3’.  [Cy5] 
indicates a Cy5 label, while [dT_NH2] indicates the presence of an amino linker 
for labeling with Cy3 post synthesis.  In the [C 2’-methoxy] modification, the 
hydroxyl group on the 2’ position of the ribose is replaced with an O-methyl 
group, inhibiting the RNA self-cleavage reaction described previously (Figure 
2.2). 
Oligonucleotides were deprotected by a two-step protocol as suggested 
by the manufacturer and previously described (see Appendix B for detailed 
protocol) [Per02].  Deprotected RNA was purified by denaturing 15% 
polyacrylamide, 8 M urea gel electrophoresis.  Bands of interest were diffusion 
eluted into 1 mM EDTA overnight at 4˚C, chloroform extracted and ethanol 
precipitated.  Pure RNA was isolated using either C8 or C18 reverse-phase 
HPLC with a linear acetonitrile gradient in triethylamonium acetate as describe 
previously [Per02].  The RNA concentration was qualified by UV absorption at 
260 nm with a correction background at 320 nm.  For fluorescence 
measurements, substrate oligonucleotides were labeled with Cy5 presynthetically 
and with Cy3 postsynthetically, as previously described (see Appendix B for 




Table 3.2 All oligonucleotide sequences used in various experiments. 
Name Type Sequence (5’ – 3’) 
RC Cleavable RNA 
substrate 
[Cy5] UAC CCG UCU GUU GUA [dt_NH2] UC AUU CUA 
UCC UCC UUU CAC UUA GU 
NC Non-cleavable 
RNA substrate 
[Cy5] AUC CCG U [C 2’-methoxy] U GUU GUA [dT_NH2] UC 
CCA AAA AAA AAA AGC CGU AAA CU 
pRC 19 nt DNA primer 
specific to RC tail 
region 
ACT AAG TGA AAG GAG GAT A  
pNC 19 nt DNA primer 
specific to NC tail 
region 
AGT TTA CGG CTT TTT TTT T  
mRC DNA sequence 
based on pRC 
printed on 
microarray 
ACT AAG TGA AAG CAG GAT AAC TAA CTA ACT AAC TAA 
GTG AAA CGA GGA TA 
mNC DNA sequence 
based on pRC 
printed on 
microarray 
AGT TTA CGG CTT TTT TTT TTT GGA GTT TAC GGA GTT 
TAC GGC TTT TTT TT 
mpRC-C3 DNA probe 
specific to mRC 
[Cy3] TAT CCT CCT TTC ACT TAG T 
mpNC-C5 DNA probe 
specific to mNC 
[Cy5] AAA AAA AAA GCC GTA AAC T 
3.3 In Vitro Transcription of HHT5 Hammerhead 
Upstream and downstream single-stranded DNA primers for the 
transcription of the HHT5 construct was purchased from Invitrogen with the 
following sequences:  HHT5 5’ primer: 5’- TAT ATA TCC CGT TTC GAC GTC 
TGC CAA GGG CCT TTC GGC TGG TAT AAG GCT CAT CAG TGT TGT ATC 
TAT AGT GAG TCG TAT TAC TG – 3’; T7 promoter sequence: 5' - CAG TAA 
TAC GAC TCA CTA TAG - 3'.   
The HHT5 hammerhead was generated by in vitro transcription in a 
reaction containing 3 micromolar of each primer, PEG, and 4X Reaction Buffer 
(HEPES-KOH pH 7.5, MgCl2, Spermidine, DTT, 1% Triton X-100) and is 
described in further detail in Appendix B. The reaction is heated in a 90˚C heat 
bath for 3min then cooled on ice.  After the addition of ATP, UTP, CTP, GTP, PPi 
0.1 u/μl (Pyrophosphatase inorganic) and T7 Polymerase, the reaction is 
incubated for at least 3 hours at 37 ˚C.  The reaction is then stopped and the 
RNA is phenol/chloroform extracted, concentrated, and gel purified to extract the 
final HHT5 product.  
 26
 
3.4 DNA Primers Designed for Microarray Printing 
DNA primers for microarray printing were designed based on the 19 nt 
primers complementary to the RNA substrate sequences.  Hybridization to 
printed DNA oligonucleotides occurs at higher rates for longer sequences, with a 
minimum length of 50 nt for printing, as suggested by the Microarray Core at the 
University of Michigan Comprehensive Cancer Center (UMCCC) .  Therefore, the 
19 nt primers were extended by repeating the sequences, resulting in the design 
of the following sequences:  for cleavable version, mRC: 5’- ACT AAG TGA AAG 
CAG GAT AAC TAA CTA ACT AAC TAA GTG AAA CGA GGA TA -3’; and for 
non-cleavable version, mNC: 5’- AGT TTA CGG CTT TTT TTT TTT GGA GTT 
TAC GGA GTT TAC GGC TTT TTT TT -3’.   
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CHAPTER 4  
OPTICAL MEASUREMENT TECHNIQUES 
4.1 FRET as a Measurement Technique 
Equation Chapter 4 Section 1Fluorescence (or Förster) resonance energy 
transfer (FRET) is a non-radiative process transferring the excited state energy 
between two fluorophores, a donor and acceptor. This has proven to be a 
powerful tool for single molecule experiments [Ha01, Kri01, Wal01] and allows for 
the measurement of distances in the 10 – 75 Å range, well below the resolution 
limit of the optical microscope [Vog06, Rue06].  In this process, excitation energy 
of the donor is transferred to the acceptor via an induced dipole-dipole interaction 
without the involvement of an intermediate photon.  FRET can occur if the 
emission spectrum of the donor overlaps sufficiently with the absorption 
spectrum of the acceptor.   








⎛ ⎞= ⎜ ⎟
⎝ ⎠
 (4.1) 
where r is the distance between the donor and acceptor, τD is the lifetime of the 
donor in the absence of energy transfer and R0 is the Förster distance [For48].  
The Förster distance is defined as the distance at which 50% of the energy is 
transferred and is a function of the absorption and emission spectrum of the 
fluorophores, as well as their relative orientation [Ha01].  The typical range for R0 
is between 20 – 60 Å, which translates to approximately 6 – 18 nt.  This value of 
R0 (nm) can be calculated using 
 
12 2 4 6
0 2.11 10 [ ( ) ]DR Jκ λ η
− −= × Q  (4.2) 
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where κ2 is the orientation factor describing the relative spatial orientation 
between the transition dipoles of the donor and acceptor, J(λ) is the overlap 
integral of the donor emission and acceptor absorption spectra, η is the refractive 
index of the medium, and QD is the quantum yield of the donor [Oly07].   
The orientation factor, κ2 is typically assumed to be 2/3 if the geometry of 
the fluorophore is not rigid or limited by steric effects.  This assumed value 
results from the randomization of the orientation of the donor and acceptor by 
rotational diffusion prior to energy transfer [Lak99].  The orientation factor can 
range from zero to 4, depending upon the relative orientations in space of the 
donor emission dipole and the acceptor absorption dipole.  A value of 1 
corresponds to parallel transition dipoles, while a value of 4 results from dipoles 
that are both parallel and collinear [Oly07].  For a two-fluorophore system, κ2 is 
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where, θT is the angle between the emission transition dipole of the donor and 
the absorption transition dipole of the acceptor, θD and θA are the angles between 
these dipoles and the vector joining the donor and acceptor, and φ is the angle 
between the planes containing the two transition dipoles.  For a completely fixed 
relative fluorophore orientation, κ2  would be known; however, for a solution-
based system, the value is difficult to determine [Wal01].   
The efficiency of energy transfer, E, is a measure of the fraction of 
photons absorbed by the donor that are transferred to the acceptor.  This value is 













FRET efficiency can also be written in terms of the donor and acceptor 












where γ is the acceptor-to-donor ratio of the products of fluorescence quantum 
yield and the instrument detection efficiency in the respective channel [Ela03, 
Rue05].  Typically, this factor is close to unity, so equation (1.5) is often simplified 
to 
 [ ] 1D AE  1  I I
−≈ + . (4.6) 
Since single-molecule studies concern mostly relative changes in the FRET 
signal, the approximation does not affect most of the data interpretation [Ha01]. 
The FRET pair commonly used in single molecule FRET, and therefore 
used in this experiment is Cyanine 3/Cyanine 5, or Cy3/Cy5, developed by 
Amersham Biosciences [Ame07].   The Jablonski energy diagram for this pair is 
given in Figure 4.1(a).  The donor fluorophore, Cy3, is excited maximally at 550 
nm and emits maximally at 570 nm, in the yellow/orange spectrum, while the 
acceptor, Cy5, is excited maximally at 649 nm and emits maximally at 670 nm, in 
the red spectrum.  Figure 4.1(b) shows the absorption (blue peaks) and emission 
(red peaks) scans of a Cy3 donor (left peaks) and Cy5 acceptor (right peaks) pair 
[Ame07]. The spectrum has been normalized to give an indication of the degree 
of spectral overlap (green region), allowing the donor to fluoresce in the acceptor 
channel.  Figure 4.2 shows a plot of the energy transfer efficiency for a Cy3 
donor and Cy5 acceptor pair.  The strong distance dependence on the energy 
transfer efficiency can be clearly seen, indicating that both cleavage and 
conformational changes of the aptazyme can be quantified.  
 
Figure 4.1 (a) A simplified Jabłonski diagram for a FRET pair.  The values included are the 
excitation and emission wavelengths for a Cy3/Cy5 FRET.  (b) Normalized absorption (blue) and 
emission (red) spectra for Cy3/Cy5.  The green area indicates the region of spectral overlap for 
FRET.  Image reproduced from Amersham Biosciences. 
 30
 
Cy5 is widely used as an acceptor fluorophore because its high extinction 
coefficient allows it to be paired with a donor with a large spectral separation 
while maintaining a relatively large Förster distance [Ras06].  However, Cy5 is 
sensitive to the electronic environment it resides in and conformational changes 
of the substrate may produce an enhancement or quenching of the fluorophore 
emission.   Additionally, Cy5 shows extensive blinking that is greatly affected by 
the presence of oxygen, which may require the use of an oxygen scavenger 
system.  This indicates that triplet states are a possible source of fluctuations as 
well as radical cation and cis–trans isomerizations [Hua06]. 
 
 
Figure 4.2 Energy transfer efficiency plot for a Cy3/Cy5 pair. Image reproduced from [Ame07]. 
4.2 Fluorophore Photobleaching 
Photobleaching is an inherent property of organic dyes and effectively 
limits the number of meaningful FRET measurements on a single molecule.  
Therefore, in single-molecule experiments, a tradeoff is made between the signal 
strength (photon-emission rate), photobleaching rate, and saturation; all 
dependant on laser excitation power.  Photobleaching is the result of an 
increased reactivity of the fluorophore in its excited states, leading to irreversible 
loss of emission, or fluorophore destruction.  This is usually due to a 
photochemical reaction [Kon07]. 
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Photobleaching is a major impediment in single-molecule spectroscopy.  
Antioxidant additives have been shown to reduce photobleaching [Ras06, Ha03] 
by preventing oxidation when in the triplet state, though this is only a partial 
solution.   
4.3 TIRF Microscopy for Single-Molecule Measurements 
In total internal reflection fluorescence microscopy, or TIRF microscopy, 
has been previously used in the Walter Lab for single molecule FRET detection 
[Wal02a, Wal02b, Zua02].  TIRF microscopy employs the unique properties of an 
induced evanescent wave to selectively illuminate and excite fluorophores in a 
region immediately adjacent to a glass-buffer interface.  An excitation light beam 
travels through a prism or objective, to reach the solid glass or quartz slide at a 
high incident angle, θ, greater than the critical angle, θc.  The critical angle, given 
by Snell’s law as  
 1 2sin c n nθ =  (4.7) 
the beam of light is totally reflected from the slide/buffer interface. Here, n1 and n2 
are the indices of refraction of the slide and buffer, respectively.  The reflection 
generates a very thin electromagnetic field, usually less than 200 nanometers, in 
the aqueous medium, which has an identical frequency to that of the incident 
light. This evanescent field undergoes exponential intensity decay with increasing 
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where Iz represents the intensity at a perpendicular distance z from the interface 
and I0 is the intensity at the interface. The characteristic penetration depth, d, at 










,   (θ > θc) (4.9) 
The penetration depth, which usually ranges between 30 and 300 nm, is 
independent of the incident light polarization direction, and decreases as the 
reflection angle grows larger. This value is also dependent upon the refractive 
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indices of the media present at the interface and the illumination wavelength, 532 
nm. 
4.3.1 Single Molecule FRET Using TIRF 
The evanescent field produced in TIRF can be used to excite the donor 
fluorophore, and therefore allowing FRET to occur between the donor and 
acceptor, as seen in Figure 4.3. The FRET between the donor and acceptor 
fluorophores can then be detected. However, once the RNA substrate is cleaved, 
only the donor fluorescence can be detected as the acceptor will leave the 
evanescent field.  As the penetration depth of the evanescent field is on the order 
of ~200nm, molecules farther away from the slide surface are not exposed to 
excitation light, and therefore do not give rise to a background signal. 
 
Figure 4.3  Cy3/Cy5 donor-acceptor labeled RNA substrates are bound to specific DNA 
oligonucleotides that are immobilized on a quartz coverslip through a biotin-streptavidin 
interaction.  Once the aptazyme binds an analyte molecule, it is catalytically and cleaves the 
substrate molecule.  Upon cleavage, FRET between a donor-acceptor fluorophore pair breaks 
down, leading to a change from a donor to an acceptor dominated fluorescence signal.  Prism-




4.3.2 Optical Setup 
Figure 4.4 shows a schematic of the TIRF microscopy setup used for 
single molecule studies.  Prism-based TIRF, as opposed to objective-based 
TIRF, is used because of the wider excitation area, flatter illumination field, 
superior contrast and greater signal-to-noise ratio [Axe01, Oly07].  A 535 nm 
beam from a picosecond-pulsed Spectra Physics Titanium:Sapphire laser passes 
through an electronic shutter, filter, λ/2 plate and polarizer before passing 
through a quartz prism at a high incidence angle to create the excitation field.  
The resulting fluorescence beam passes through the Olympus IX71 inverted 
fluorescence microscope to a 630 nm dichroic to separate the Cy3 and Cy5 
fluorescence beams.  Each beam is then focused adjacent to one another onto a 
Roper Scientific I-PentaMAX intensified CCD for imaging.  This allows both 





Figure 4.4 Schematic of the TIRF microscopy set-up used for single-molecule studies. The setup 
involves prism-based total internal reflection excitation at 532nm on an Olympus IX71 inverted 
fluorescence microscope.  The resulting donor/acceptor emission is separated using a 630nm 
dichroic mirror (transmitting wavelengths <630nm and reflecting wavelengths >630nm) and one 
arm is spatially shifted so that the resulting two images will be projected side-by-side onto the 




Figure 4.5 False color image of the Cy3 (left) and Cy5 (right) channels focused onto the imaging 
CCD. 
4.3.3 Flow Cell Preparation 
The platform on which single molecule experiments are conducted is a 
flow cell made using an ultra-clean quartz slide, ensuring the index of refraction 
the excitation beam encounters upon entering the prism does not change.  As 
quartz slides are not as readily available as their glass counterparts, these slides 
are reused.  Therefore, to ensure no RNases are present, as well as to limit any 
background fluorescence, an extensive cleaning and preparation process is 
used.   
If the slides have been used previously, they are boiled in water with a stir 
bar for about 20 min to soften any epoxy glue.  When the epoxy turns yellow, it is 
carefully scraped away, along with the coverslip, with a razor blade.  The slides 
are then cleaned with a very thick paste of Alconox and water mixture by rubbing 
them thoroughly and rinsing with water to ensure all of the detergent is removed.  
 36
 
Finally, the slides are rubbed with ethanol, rinsed with ethanol, and rinsed with 
water, resulting in perfectly clean slides.   
The slides are then placed in a pre-wash solution of 100ml autoclaved 
water, 20ml of 30% Ammonium Hydroxide, and 20ml of 30% Hydrogen Peroxide.  
This solution is then placed on a hot plate and heated, covered, on a hot plate, in 
the hood for 20 min while being slowly mixed with a stir bar.  The slides are then 
rinsed with water and dried by passing each side at least 10 times slowly over a 
flame.  Immediately after cooling, a coverslip is adhered to each slide to limit the 
amount of air that the measurement surface is exposed to.  This will minimize 
contamination.   
To adhere a coverslip, two strips of double-sided tape are first placed 
diagonally on the slide and parallel to the line defined by the previously drilled 
holes.  The tapes are placed such that there is a hole in the upper left and lower 
right corners and the separation between them is approximately 4 – 6 mm.  A 
second layer of tapes is applied and a fresh cover slip is centered on top.  The 
excess tape is then removed with a razor blade and all sides are sealed using a 
quick-setting epoxy glue.  The slides can now be stored for several months if 
covered.  
To fill the flow-cells with a pipette, about 2 – 3 mm of the cone end of the 
pipette tip must be cut off with a razor blade and the tip snugly fits into the 
injection hole. The liquid injected into the slide should flush the channel and just 
flow out of the second injection hole. If the tip flows well, it is kept for all 
injections.  
4.4 Confocal Fluorescence Imaging  
Confocal imaging microscopy was pioneered in 1955 by Marvin Minsky 
while he was a junior fellow at Harvard University [Min88].  Modern confocal 
imaging has preserved the essence of Minsky’s design while incorporating new 
advances in optics and electronics to provide improvements in speed, image 
quality, and data acquisition and storage.  The typical confocal microscope 
images either by reflecting light off of a specimen or by stimulating a fluorophore 
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applied to the specimen [Sem05, Wal03a, Wal03b].  The latter is the more 
common technique used in biological applications, such as in scanners used for 
imaging microarrays.   
4.4.1 Confocal Imaging System  
The confocal microscope incorporates the concepts of point-by-point 
illumination and rejection of out-of-focus light.  In Figure 4.6, laser light reflects off 
of a beamsplitter, or dichroic lens, and passes through an objective which 
focuses the light onto the sample.  The longer-wavelength fluorescence beam 
resulting from this excitation passes through the beamsplitter to a filter wheel, 
which filters the wavelength of interest.  This beam then travels through a pinhole 
which allows only focused light to pass to the detector element, usually a CCD.   
 
 
Figure 4.6 Schematic of the basic setup of a confocal imaging system utilized by a microarray 
scanner.  Light from a laser is reflected off of a beamsplitter, or dichroic mirror, toward the 
sample.  The returning (longer wavelength) fluorescence is allowed to pass through the dichroic, 
where it is filtered according to wavelength of interest, before reaching the detector element. 
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4.4.2 Microarray Scanner Function 
The microarray scanners used for data acquisition are the PerkinElmer 
ScanArray Express, in the Richard Miller Laboratory of Gerontology, and the GSI 
Lumonics ScanArray 5000, in the Robert Thompson Laboratory at the Molecular 
and Behavioral Neuroscience Institute.  These scanners have several pre-
installed excitation lasers and emission filters, as well as software with pre-
determined laser/filter combinations specific to a variety of common fluorophores.  
For the fluorophores of interest, the excitation lasers emit at wavelengths of 543 
nm for Cy3 excitation and 633 nm for Cy5 excitation.   570 nm and 670 nm 
10 nm bandwidth emission filters are used for detection of Cy3 or Cy5 
fluorescence.  As the scanner software allows for the customization of 
fluorophores, a “FRET fluorophore”, that uses the 543 nm excitation laser and 
670 nm emission filter, can be defined and subsequently used to measure FRET 
between Cy3 and Cy5, as indicated by Figure 4.7.   
The goal of confocal microscopy is to see the image at only one point, 
consequently making this detection method very sensitive to the focus. The 
sample must also be scanned to create an image of a thin planar region of the 
sample, an effect known as optical sectioning.  The scanners used for this 
experiment keep the optics stationary while moving the sample back and forth in 
the vertical and horizontal planes.  This method of scanning is slower than 
moving the optics, but it has two major advantages [Sem05].  First, the sample is 
illuminated axially, avoiding optical aberrations and illuminating the entire field of 
view uniformly.  Second, controlling the amplitude of the stage movement allows 
the field of view to be made larger than that of the static objective. 
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Figure 4.7 Normalized absorption (blue) and emission (red) spectra for Cy3/Cy5 showing 
excitation and emission using microarray scanner. 
4.5 Adapting Single-Molecule Experiments onto a DNA Microarray  
To develop a biosensor with the adaptability to detect multiple targets, as 
well as to incorporate the compact detection methodology afforded by microarray 
scanners, single molecule experiments were adapted onto a microarray platform.    
A microarray is a general term referring to biological assays of DNA, 
protein, tissue, chemical compounds or antibodies.  DNA microarrays are 
typically collections microscopic DNA spots arrayed on a solid surface by 
covalent attachment to a chemical matrix.  These arrays are used to either 
measure DNA or to use DNA as part of a detection system utilizing the selective 
nature of DNA-DNA or DNA-RNA hybridization.   
DNA microarrays are typically used for rapid detection of gene mutations 
[Shu97], as well as for gene expression [DeR96, DeS98, Sch96], though their 
potential applications in biosensor technology have become more apparent in 
recent years [Ben05, Che06].  For example, McCauley and coworkers utilized 
immobilized DNA and RNA aptamers to develop a biosensor for muliplex 
 40
 
analysis of protein analytes [McC03].  More recently, Collet and coworkers 
immobilized biotynolated RNA aptamers onto streptavidin coated slides in a 
microarray to develop a protein biosensor [Cho06, Col05]. 
Utilizing the DNA-RNA hybridization techniques previously described 
[Lee05], we can adapt the single molecule experiments onto a DNA microarray, 
where the DNA primers, mRC and mNC, are printed in an array such that spots 
of labeled RC and NC can be detected using a microarray scanner post DNA-
RNA hybridization.  As shown in Figure 4.8, upon introduction of the aptazyme 
and analyte, there will be a detectable signal change due to a cleavage reaction. 
 
 
Figure 4.8 Cy3/Cy5 donor-acceptor labeled RNA substrates immobilized onto a coated glass 
slide through hybridization to DNA oligonucleotides that are printed in a microarray.  Once the 
aptazyme binds an analyte molecule, it is catalytically and cleaves the substrate molecule.  Upon 
cleavage, FRET between a donor-acceptor fluorophore pair breaks down, leading to a change 
from a donor to an acceptor dominated fluorescence signal.  A microarray scanner using a 
confocal imaging system is used to excite the donor fluorophore and measure the resulting 
fluorescence signal. 
4.5.1 Microarray Chip Design 
Microarrays are printed using a robot spotter with one or more quills that 
are dipped into solution stored in a 384-well microplate and then lightly tapped 
onto a slide surface, depositing a uniform amount of solution onto the slide 
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surface.  Spots are typically deposited in a grid pattern, often called a 
constellation, on the slide surface.  After printing, slides may be crosslinked by 
UV light, heat treated, or simply allowed to dry at room temperature.  Slides are 
printed by the University of Michigan Comprehensive Cancer Center (UMCCC) 
Affymetrix and Microarray Core Facility using a BioAutomations MagnaSpotter 
equipped with up to four split quills and with no post-processing of the slides. 
4.5.1.1 Surface Chemistry 
Slides pre-coated for printing oligonucleotide microarrays were obtained 
from Erie Scientific Company.  The slides used are manufactured from high 
quality low fluorescence glass and coated with either inorganic (amino-silane 
(APS), ES amino-silane (ES-APS), and epoxy-silane) and organic (poly-L-lysine 
(PLL) and ES poly-L-lysine (ES-PLL)) coatings.   
Array spot-size is often controlled by the surface energy of the coating, 
where hydrophobic coatings give smaller spot sizes, while hydrophilic coatings 
give larger spot sizes.  The surface characterization information provided by Erie 
Scientific, obtained using atomic force microscopy, is shown in Figure 4.9.  For 
the enhanced surface, or ES, type of coating, acid etching is used to control the 
surface morphology of the glass, resulting in a surface with microscopic canyons 
and valleys, but still uniformly coated with functional groups. The average 
roughness of the coatings, defined as the arithmetic average of the absolute 
values of the roughness profile ordinates, is given as 0.4339 nm for the standard 
coating and 16.2485 nm for the ES coating, with average heights of respective 
surface features of 5.2893 nm and 83.8990 nm [Eri07].  The benefit of the ES 
surface is that it allows for spotting of smaller, more uniform spots without 
affecting the focusing or use of microarray spotters and scanners.  
Finally, microarrays printed on slides with inorganic coatings showed no 
effects from degradation after six months, while those printed on organic coatings 
showed some degradation in this time period.  However, qualitative comparisons 
of signal-to-noise levels conducted by staining stamped arrays with SyBr Green 
and DNA-DNA hybridization showed that microarrays printed on the thicker ES 
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slides did not show a significant improvement in spot quality.  Therefore, for the 
current biosensor design, the surface coatings do not have a significant effect on 
the microarray print quality. 
 
Figure 4.9  Surface characterization profiles, provided by Erie Scientific Company, for standard 
coatings (left) and Enhanced Surface, ES, (right) coatings. The average roughness values of the 
coatings are given as 0.4339 nm for the standard coating and 16.2485 nm for the ES coating, 
with average heights of surface features of 5.2893 nm and 83.8990 nm, respectively. 
4.5.1.2  Array Design 
DNA oligonucloetides for stamping were designed based on the DNA 
primers specific to the cleavable (RC) and non-cleavable (NC) versions of the 
RNA substrate described earlier.  Figure 4.10 shows a schematic of a 
constellation design incorporating arrays of these DNA oligonucleotides, mRC 
and mNC, printed in rows of increasing concentration.  Asymmetrically located 
calibration spots, composed of a mixture of mRC and mNC, were added to the 
array to ensure proper orientation of the array during measurement.  These spots 
are also used to manually locate and focus the array during scanning.  The mRC 
and mNC arrays are separated within the constellation with spots of buffer for 
background measurement and to prevent cross-contamination of the spots 
during the printing process.  Spots stamped with air, rather than buffer, showed 
some residue even with pin cleaning.  Several generations of this design, using 
the same concentrations of mRC and mNC were used for experimentation. 
DNA for printing is prepared using the protocols required by the UMCCC 
[Was06].  DNA is suspended in a standard stamping buffer of 3X SSC with a 
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minimum concentration of 0.5 μg/μl.  Therefore, aliquots of DNA primers of the 
following concentrations – 0.5 μg/μl, 1.5 μg/μl, 5 μg/μl, and 15 μg/μl – in standard 
stamping buffer were prepared, as well as the 5 μg/μl, 3X SSC primer mixture.  
Using a 384 well plate, appropriate wells were filled with 3 μl of solution.  The 
printing order for the first quill is as follows: A1, A2, B1, B2, A13, A14, B13, B14, 
C1, C2, D1, D2, C13, C14, etc.  For the remaining three quills, which were not 
used, the pattern can be repeated, but shifted to the right. 
 
Figure 4.10 Schematic of a constellation design where arrays of the DNA oligonucleotides, RCm 
and NCm (yellow and blue circles), are printed in rows of increasing concentration (0.5 μg/μl, 1.5 
μg/μl, 5.0 μg/μl, and 15 μg/μl).  Green circles indicate calibration spots composed of a 0.5 μM 
mixture of RCm and NCm.  Grey circles indicate buffer spots. 
Variations in spot size and shape can be caused by a variety of factors, 
including the robot’s dwell time on the slide, the slide’s coating, the solution 
viscosity, and environmental factors, such as humidity and temperature.  
However, spots printed using a robot spotter typically have a diameter of 
approximately 120 μm. 
4.5.2 Preparation and Hybridization of Microarrays 
The specific protocols followed in the preparation of the printed microarray 
slides for hybridization and subsequent experimentation are described in more 
detail in Appendix B.  These protocols are based on the procedures previously 
described in literature [Beh02, Bro99, Cos05, Loc00, Tay03, Wal00]. 
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4.5.2.1 Blocking Strategy 
To effectively inactivate reactive groups that may remain post-printing on 
coated microarray slides and prevent the labeled substrate from adsorbing into 
the surface of the printed microarray during hybridization, the exposed surfaces 
must be blocked using a blocking buffer.  Blocking methods also wash away any 
unwanted DNA from the surface that might otherwise compete with the labeled 
substrate [Tay03].  Therefore, background noise will be reduced while 
maintaining full signal intensities.  
Two of the most common blocking methods to address non-specific 
adsorption involve blocking with succinic anhydride or bovine serum albumin 
(BSA) [Tay03].  Both strategies are intended to block the unreacted functional 
groups of the printed microarray with chemistries that have a low affinity for RNA 
or DNA.  The latter strategy, using BSA – a large, globular protein with 
hydrophobic regions which enable it to stick to glass – is employed here.  Also 
included in the blocking buffer is sodium dodecyl sulfate (SDS), an anionic 
surfactant with a hydrophilic head and hydrophobic tail, as well as EDTA, which 
complexes divalent ions which cause NA’s to collapse. 
 Therefore, the blocking buffer composed of 5X SSC pH 7.0, 0.5% SDS, 
0.1 mM EDTA pH 8.0, and 1% BSA must first be incubated at 42˚ for 30 min.  It 
is interesting to note that this blocking buffer does not lose its effectiveness when 
adjusted to contain 3X SSC but will not show visible precipitant when stored at 
RT.  Approximately 40 μl of this buffer is spotted onto each constellation and 
covered with a coverslip.  The slide is then incubated in a humid environment at 
42˚C for 30 min upon which the coverslip is removed and the slide is placed in a 
Coplin jar filled with ddH2O and shaken for 1-2 min to wash.  The slide is washed 
in this manner four more times in ddH2O and once in isopropanol before being 
allowed to air dry.  The slide is now ready for hybridization. 
4.5.2.2 Hybridization of RNA Substrate 
In a hybridization reaction, labeled molecular targets, such as the doubly-
labeled RNA substrate, are transported from a bulk sample volume to a 
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hybridization site by both diffusion and convection.  At the hybridization site, the 
substrate will hybridize to a complementary region of the DNA primer.  It is 
imperative to hybridize under controlled environmental conditions to ensure 
strong and irregular streaks of high-intensity background that is typically caused 
by evaporation and subsequent drying of the hybridization buffer [Cos05]. 
To isolate the constellations during the hybridization stage and to minimize 
the amount of material needed, small hybridization chambers are cut out of 
double-sided tape and placed around the constellations.  Hybridization buffer 
composed of 50% formamide, 5X SSC, 0.1% SDS, 1/40 herring sperm DNA, and 
1/10 RNA substrate is heat annealed at 90˚C for 2 min then cooled on ice.  The 
hybridization chambers are then filled and covered with a glass coverslip.  The 
slides are then incubated in a dark and humid environment at room temperature.  
Hybridization times is dependant on nucleotide lengths, the hybridization buffer, 
specifically the formamide content, as well as whether the hybridization is 
between DNA-DNA and RNA-DNA.  For the former, we incubate for 1.5 hours; 
for the latter, 6 hours. 
Post incubation, the coverslips and hybridization chambers are removed 
and the slide is washed by agitating for 5 min in each wash buffer I, II, III and 
finally in ddH2O.  Wash buffer I is composed of 1X SSC, 0.2% SDS; II is 
composed of 0.1X SSC, 0.2% SDS; and III is composed of 0.1X SSC.  After 
washing, the slide is allowed to air dry in a dark environment and stored at 4˚C to 
prevent premature photobleaching of the fluorophores. 
4.5.2.3 Flow Cell Preparation 
To create a flow cell around the RNA-DNA hybridized constellations, a 
flow cell pattern is cut out of parafilm and placed around each constellation.  
Next, a washed and plasma-cleaned coverslip is placed atop the parafilm and the 
excess parafilm is cut away.  A soldering iron is used to melt the parafilm, 
securing the coverslip to the slide and completing the flow cells shown in Figure 
4.11.  A soldering iron is used to melt the parafilm instead of the conventional hot 
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plate because the iron will apply heat to a localized area and melt the parafilm 
without introducing a significant amount of heat to the RNA-DNA array.   
Recall that the microarray scanner moves the sample, as opposed to the 
optics, when imaging.  As microarray slides are typically scanned when dry, this 
feature does not normally present any negative effects.  However, my 
measurements are done in a fluid environment and the very quick movement of 
the slide causes buffer to splash out of the inlet and outlet of the flow cell.  This 
effect results in a change in the experimental environment over time and 
therefore must be prevented.  To this end, once the final sample solution has 
been introduced into the flow cell, high viscosity vacuum grease is used to seal 
the inlet and outlet of the flow cell.  In practice, this has proven to be a very 
effective method to maintain the integrity of the experimental environment. 
 
 
Figure 4.11  Microarray flow cells.  Two microarray constellations are printed on each glass slide.  
The constellations are surrounded by a parafilm channel, atop which the coverslip is placed.  The 
parafilm is melted using a soldering iron, adhering the coverslip to the slide and creating a flow 
channel for measurements in a fluid environment.  Once fluid is introduced into the channel, the 
inlet and outlet are sealed using vacuum grease. 
4.5.3 Controls and Calibrations 
To ensure FRET measurements are feasible using microarry scanning 
techniques, several proof-of-principle and calibration tests were conducted on the 
system.  Therefore, we must check for quality and specificity in hybridization of 
the substrates (RC or NC) between the cleavable and non-cleavable regions of 
the microarray constellations, ensure good signal–to–noise ratio in appropriate 
channels and determine the extent of signal bleed–through between channels.  
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Short, singly labeled DNA probes specific to the RC and NC regions, mpRC-C3 
and mpNC-C5, are used for these calibration tests.  Singly labeled RNA is also 
used to ensure hybridization specificity and quality. 
Figure 4.12 shows the result of the calibration tests using DNA-DNA 
hybridization, where the rows of figures show the channel signals for the Cy3 
singly-labeled DNA probe (top row) and Cy5 singly-labeled DNA probe (bottom 
row).  As expected, Figure 4.12(a) shows strong signal strength in the Cy3 
channel with good spotting quality, where the spots are round and evenly 
spaced.  The intensity of the spots increases with row, with the concentration of 
DNA in stamping solution, but does not saturate. Also, negligible non-specific 
binding exists, indicating good pre-hybridization blocking.  As the DNA probe is 
singly labeled with Cy3, there is no signal in the CY5 channel Figure 4.12(b); 
however, an average signal bleed-through into the FRET channel of 
6.45 ± 0.75 % Figure 4.12(c) is observed.  Bleed-through of about 7% is 
expected due to the spectral overlaps shown in Figure 4.7 indicating that the 
correct channel settings are used. 
The results of the hybridization of the Cy5 singly-labeled DNA probe are 
shown in Figure 4.12(d), (e), and (f).  In (d), a negligible signal is seen in the Cy3 
channel.  This signal is a result of the scattering of laser light off of surface 
artifacts left behind in the stamping process.  There is a strong signal in the Cy5 
channel, (e), however the spot quality is not as good on this half of the 
microarray constellation.  This is simply due to poor printing procedure, where 
either the slide(s) or the 384-well microplate were not level during the printing 
process and should not affect future experiments.  Finally, there is no signal in 
the FRET channel, as there is no fluorophore excitation at 543 nm or bleed-
through into this channel. 
 NC substrate, both singly labeled with Cy5 and doubly labeled, was used 
to test the quality of RNA-DNA hybridization. Figure 4.13 shows the results of the 
hybridization of NC to a first-generation microarray constellation, where the top 
row of images is of singly-labeled RNA while the bottom row is of doubly-labeled 




(c), but a strong signal in (b), as expected.  The spot quality in (b) is sufficient to 
extract data and the signal does not saturate.  In the bottom row of images in 
Figure 4.13, (d) shows a relatively weak signal in the Cy3 channel, a stronger 
signal in the Cy5 (e), and the strongest signal in the FRET channel (f).  This 
indicates that FRET occurs between the Cy3 and Cy5 fluorophores on the NC 




Figure 4.12 Singly labeled DNA primers hybridized to microarray to test specificity and channel quality. The signals from a Cy3 singly labeled DNA 
probe in all three channels are shown in (a), (b), and (c). In (a), the strong signal shows highly specific hybridization of the singly labeled probe 
DNA to its respective printed spots. (b) No excitation of the Cy3 fluorophore in the Cy5 channel.  (c) The extent of signal bleed-through of the Cy3 
fluorophore in the FRET channel resulting from the spectral overlap seen in Figure 4.7. The signals from a Cy5 singly labeled DNA probe in all 
three channels are shown in (d), (e), and (f). In (d), there is no signal in the Cy3 channel. The strong signal in (e) shows highly specific 





Figure 4.13 Singly (top) and doubly (bottom) labeled NC RNA hybridized onto a microarray chip 
to test hybridization quality as well as the three measurement channels: Cy3 (a) & (d), Cy5 (b) & 





5.1  Bulk Measurements 
5.1.1 Steady state FRET assays 
Equation Chapter 5 Section 1Steady-state FRET assays are performed to 
monitor the FRET breakdown that occurs upon substrate cleavage as well as to 
measure rates of binding and dissociation of the substrate and cleavage 
products.  Steady-state fluorescence spectra were recorded on an Aminco-
Bowman Series 2 spectrofluorometer using the HHT5 complex consisting of the 
HHT5 ribozyme, doubly labeled RNA substrate and biotynolated DNA primer.  
The annealed ribozyme (final concentration of 50 nM based on the concentration 
of the substrate strand; with a 4-fold (saturating) excess of both HHT5 ribozyme 
and DNA primer was incubated at 25 oC for at least 15 min in standard buffer (50 
mM Tris-HCl, 10 mM MgCl2), supplemented with 25 mM β-mercaptoethanol as a 
radical quencher, and was then transferred to a 150 μL cuvette.  Cy3 was excited 
at 540 nm (4 nm bandwidth) and fluorescence emission was recorded 
simultaneously at the Cy5 (665 nm, 8 nm bandwidth) wavelength.  The PMT 
voltage was set to 945V.  Theophylline solution was manually added to a 
concentration of 500 nM.  The resulting time traces, an example of which is 
shown in Figure 5.1, were fit to a single-exponential decrease  
 1
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Figure 5.1 Steady state fluorescence time trace for a cleavage experiment.  Initially, only 50 nM 
RC and 50 nM biotinolated pRC are present in 50 mM TRIS-HCl, pH 7.5, 10 mM MgCl2 and the 
fluorescence is constant.  At t = 75 sec (a), 150 nM HHT5 solution is introduced into the system 
and background cleavage of the substrate is observed.  At approximately t = 300 sec (b) 1.5 mM 




Figure 5.2 Steady state FRET assay data showing the FRET ratio as a function of time for the 
doubly-labeled RC substrate + HHT5 complex.  This is the background cleavage. 
The FRET ratio as a function of time based on the fluorescent signals of 
the acceptor and donor fluorophores in the presence of a three-fold concentration 
of HHT5 is shown in Figure 5.2.  This is the background cleavage activity of the 
ribozyme, with a measured value of kobs = 0.007418 ± 0.001086 s-1.  Upon the 
addition of some concentration of theophylline, an increase in kobs is expected, 
indicating cleavage due to the presence of the analyte. However, a decrease in 
kobs is consistently measured.  Figure 5.3 shows the FRET ratio as a function of 
time for the doubly-labeled HHT5 ribozyme complex upon the addition of 50 mM 
theophylline.  The FRET decay is expected to be due to the cleavage of the RC 
substrate and is faster than the decay due to photobleaching and background 
catalytic activity.  The cleavage rate is measured to be kobs = 
0.00198 ± 0.00005 s-1.   Upon the addition of a higher concentration of 
theophylline, as in Figure 5.4, a faster cleavage rate is expected than for 50 mM 
theophylline.  However, for 1.5 mM theophylline, the cleavage rate is observed to 
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be kobs = 0.00102 ± 0.00009 s-1.  The results of several experiments at various 
theophylline concentrations are shown in Figure 5.5.  A higher kobs is observed in 
the presence of theophylline and the rate is concentration dependent, increasing 
with concentration, not as expected. 
 
Figure 5.3 Steady state FRET assay data showing the FRET ratio as a function of time for the 
doubly-labeled RC substrate + HHT5 complex upon the addition of 50 μM theophylline.  The 
FRET decay is due to the cleavage of the RC substrate and is slower than the decay due to 




Figure 5.4 Steady state FRET assay data showing the FRET ratio as a function of time for the 
doubly-labeled RC substrate + HHT5 complex upon the addition of 1.5 mM theophylline.  The 
FRET decay is due to the cleavage of the RC substrate and is slower than the decay observed 
for the complex in the presence of 50 μM theophylline. 
 
Figure 5.5 The measured rates of decay at various theophylline concentrations.  A faster rate of 
decay is observed in the presence of theophylline. 
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The results of the steady state FRET assays do not show the viability of 
this ribosomal complex as the basis for a theophylline-specific biosensor.  AThe 
expected difference in the rate of cleavage due to the presence of theophylline is 
not clearly observed in bulk solution.  However, whether the expected response 
of the complex can be observed on the single-molecule level is yet to be 
determined.  As the experimental environment plays an important role in the 
cleavage reaction, specifically the temperature and divalent ion concentration, 
this environment must first be studied and carefully monitored. These studies 
take the form of radioactive cleavage assays. 
5.1.2 Radioactive cleavage assays and titrations 
The (non-fluorescently) 5’32P-labeled substrate was prepared by 
phosphorylation with T4 polynucleotide kinase and [γ32P]ATP.  
HHT5 complex was pre-annealed from <1 nM labeled substrate, 50 nM 
HHT5 ribozyme and 300 nM non-biotynolated DNA primer in standard buffer, by 
heating to 70 oC for 2 min and cooling to room temperature. After pre-incubation, 
theophylline buffer was added, as appropriate.  Aliquots (2 μL) were taken at 
appropriate time intervals and the reactions quenched with 13 μL of 80% 
formamide, 0.025% xylene cyanol, 0.025% bromophenol blue, and 50 mM 
EDTA.  The 5’ cleavage product was separated from the uncleaved substrate by 
denaturing 20% polyacrylamide, 8 M urea, gel electrophoresis (Figure 5.6)and 
was quantified and normalized to the sum of the substrate and product bands 
using a Storm 840 PhosphorImager with ImageQuant software (Molecular 
Dynamics). Time traces of product formation (Figure 5.7) were fit to the single-
exponential first-order rate equation 1.  
 /0
ty y Ae τ−= +  (5.3) 
Using Equation (5.3), we employed Marquardt-Levenberg nonlinear least-
squares regression (Microcal Origin), where A is the amplitude and τ-1 the 





Figure 5.6 Results of a radioactive cleavage assay, showing (a) the background cleavage of the 
HHT5 ribozyme and (b) the enhanced cleavage due to the presence of 10 mM theophylline. 
.
 
Figure 5.7 Radioactive cleavage assay results showing an enhancement of the catalytic activity of 
the HHT5 ribozyme in the presence of 0.1 mM theophylline.  The cleavage rates found for 0.0mM 
and 0.1mM theophylline are kobs = 0.01 min-1 and kobs = 0.03 min-1, respectively. 
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Metal ions neutralize the negatively charged phosphate backbone, 
significantly contributing to the folding of RNA molecules [Pyl02]. Furthermore, 
active tertiary conformation and catalytic function in RNA is often sensitive to the 
type and concentration of present cation(s) [Han00, Mur98].   Therefore, as the 
catalytic activity of the hammerhead ribozyme is enhanced with the concentration 
of divalent ions, several magnesium and theophylline titrations were conducted to 
determine the appropriate buffer conditions for single-molecule (and later - 
microarray) experiments.  Figure 5.8 shows the results of the magnesium titration 
conducted at a 0.1 mM theophylline concentration.  Here, we see a marked 
enhancement of catalytic activity for magnesium concentrations greater than 10 
mM, the concentration typically used for standard reaction buffer.  Subsequent 
titrations (Figure 5.9) over theophylline concentrations of interest were taken at 
10 mM and 20 mM MgCl2, showing an enhancement of catalytic activity at the 
greater magnesium concentration.  Standard experiment buffer was 
subsequently adjusted to include 20 mM MgCl2. 
Figure 5.9 shows the results of a cleavage assay performed under the 
adjusted buffer conditions.  The background cleavage rate that can be expected 
from the conformational changes of the HHT5 ribozyme, causing the ribozyme to 
undergo catalysis, was determined from the 0.0 mM theophylline data.  Thus a 
background cleavage rate of kobs = 0.0118 ± 0.0013 min-1 is expected.  For a 
concentration of 0.1 mM theophylline, the kobs = 0.0323 ± 0.0020 min-1, showing 




Figure 5.8 Magnesium titration showing an increase in the rate of cleavage of the HHT5 ribozyme 
with magnesium concentration. 
 
Figure 5.9 Theophylline titration data showing an increase in the rate of cleavage of the HHT5 
ribozyme with magnesium concentration. 
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5.2 Single Molecule Measurements 
5.2.1 Sample Preparation 
Samples for single molecule experimentation are prepared using the 
specific protocol described in Appendix B.  In short, previously prepared flow 
cells (see Chapter 4.3) were injected with 60 µl of biotinylated BSA and left to 
incubate at RT for 10 min.  The channels were then flushed with 80 µl of a 
50 mM Tris pH 7.5, 50 mM NaCl buffer to remove excess BSA and injected with 
80 µl streptavidin. After flushing the channels with 80 µl of Standard Buffer 
(50 mM Tris-HCl pH 7.5, 20 mM MgCl2), and injection with approximately 80 μl 
Sodium buffer and approximately 80 μl streptavidin, the flow cells are ready for 
sample. 
To prepare the 100 pM sample solution (Solution C), combine 4 μl of 5 nM 
solution (Solution B), 4 μl βME (Beta-mercapto-ethanol), and 192 μl Standard 
Buffer (50 mM Tris-HCl pH 7.5, 20 mM MgCl2).  Solution B is prepared by diluting 
2 μl Solution A and 4 μl βME in 194 μl Standard Buffer.  Solution A consists of 
1 μl doubly labeled RC substrate, 0.411 μl biotynolated pRC primer, 7.60 μl 
Standard Buffer and 1 μl βME.  Solution A is heat annealed at 90°C and allowed 
to cool to RT before dissolution into Solution C.  Finally, a 250 nM HHT5 
ribozyme buffer is prepared in oxygen scavenger system (OSS) buffer.  The OSS 
buffer, composed of 192 μl Glucose Buffer, 2 μl OSS, and 4 μl βME, is prepared 
from the OSS composed of 12.5 μl Catalase, 50 μl equivalent volume glucose 
oxydase, and 100μl of buffer containing 50 mM Tris-HCl and 50 mM NaCl, pH 
7.5.   
5.2.2 Single molecule FRET events 
Single molecule events are detected using the TIRF microscopy 
techniques previously described.  In Figure 5.10 through Figure 5.13, examples 
of typical single-molecule event data are shown.  Figure 5.10 shows a single 
molecule FRET event.  Here, the Cy3 donor fluorophore (blue line) transfers 
energy to the Cy5 acceptor fluorophore (red line) for approximately t = 750 sec, 
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at which point the Cy5 disappears.  This acceptor disappearance is either due to 
photobleaching or cleavage of the RNA substrate molecule.  At approximately t = 
1400 sec, the Cy3 disappears in a single step, indicating detection of a single 
molecule.  Both Figure 5.11 and Figure 5.12 show single molecule events where 
FRET cannot be conclusively determined.  In Figure 5.11, the Cy5 disappears in 
a single step at t = 350 sec, but as there is no Cy3 signal, FRET between Cy3 
and Cy5 on the same molecule cannot be ascertained and this event type is of 
no interest.  Similarly, Figure 5.12 shows an event where the Cy3 does not 
efficiently transfer energy to the Cy5.  At t = 150 sec, the donor undergoes 
photobleaching and no information is gleaned regarding the nature of the event 
and is therefore not of interest. However, the event shown in Figure 5.13 is of 
interest as this event may indicate conformational changes of the RNA complex 
in solution.  As the complex undergoes molecular dynamics, the locations of the 
donor and acceptor fluorophores change, also changing the FRET efficiency.  At 
approximately t = 6600 sec, at which point the Cy5 disappears due to either a 
photobleaching or cleavage event.  At approximately t = 7250 sec, the Cy3 
disappears in a single step, indicating the detection of a single molecule. 
 
Figure 5.10 A typical single-molecule FRET event. The donor fluorophore transfers energy to the 
acceptor fluorophore for approximately t = 750 sec, at which point the acceptor disappears either 
due to photobleaching or cleavage of the RNA substrate molecule.  At approximately t = 1400 





Figure 5.11 A single-molecule event where the acceptor fluorophore disappears in a single step 
at t = 350 sec.  FRET between fluorophores on the same molecule cannot be conclusively 
asserted in this case.   
 
 
Figure 5.12 A single-molecule event where the donor fluorophore does not efficiently transfer 





Figure 5.13 A single-molecule event which indicates conformational changes of the RNA complex 
in solution.  As the complex undergoes molecular dynamics, the locations of the donor and 
acceptor fluorophores change, also changing the FRET efficiency. 
5.2.3 Single Molecule Measurement Results 
Preliminary single molecule experiments were conducted using the 
cleavable (RC) substrate to determine the time scales of the expected 
background effects due to photobleaching and background cleavage.  The 
exposure time, from full frame to 0.192, was adjusted to determine the rate of 
background effects under these experimental conditions.  The results are shown 
in Figure 5.14 and in Figure 5.15.  At full frame exposure, the substrate is 
expected to photobleach in approximately 150 seconds, while at the shorter 
exposure, an expected photobleaching time of approximately 760 seconds was 
determined.  According to my radioactive cleavage experiment results, cleavage 
due to the presence of 0.1mM theophylline in the presence of 20mM magnesium 
concentration is expected on a time scale of approximately 1000 seconds.  
Therefore, the exposure time of the fluorophores must be decreased even more 




Figure 5.14 Single molecule cleavage event data to determine the photobleaching rate using 
cleavable (RC) substrate.  Full frame data taken at 10.12 fps shows the fluorophore exposure 
rate must be decreased. 
 
Figure 5.15 Single molecule cleavage event data to determine the photobleaching rate using 
cleavable (RC) substrate.  Data taken at 10.12 fps with a 0.192 exposure shows photobleaching 
and background cleavage to be slower than the expected theophylline-enhanced cleavage based 
on cleavage assay results. 
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5.3 Microarray Measurements 
5.3.1 Sample Preparation 
Samples for microarray experimentation are prepared based on the 
protocols for bulk and single-molecule experiments and is described in more 
detail in Appendix B.  As the microarray is printed on the surface of the glass 
slide, the preparation of the flow cell is modified.  Also, as data measurement is 
done off-site, all materials and reagents must be transported, in a light and 
temperature controlled environment. 
As the concentration of hybridized RNA substrate on the microarray is 
unknown, and can only be estimated based on the concentration of the DNA 
printed on each spot, the sample solution is prepared with an excess of HHT5.  
This solution of heat annealed 5 μM HHT5 in standard buffer (50 mM Tris-HCl, 
20 mM MgCl2) is allowed to cool on ice during transport.  Theophylline or caffeine 
may be added to the sample solution once at the microarray scanner. 
5.3.2 Experimental Results 
Various experiments were conducted to measure the cleavage rate of the 
doubly-labeled HHT5 ribozyme in the presence and absence of theophylline.  
Each microarray was repeatedly scanned to obtain time traces in the Cy3, Cy5, 
and FRET channels.  A laser power setting of 75%, PMT gain of 80% and focal 
length of approximately -50 was used for each experiment, however the values 
were adjusted for each measurement area to ensure proper focus and prevent 
signal saturation when necessary.  
5.3.2.1 Preliminary data 
Initial data taken of RC substrate hybridized onto the DNA microarray is 
shown in Figure 5.16.  Each figure represents the average fluorescent signal 
intensity over time in the Cy3 and Cy5 channels for each row of printed DNA 
primer.   
Recall that different concentrations of primer were used in the 
constellation design, 0.5 μg/μl, 1.5 μg/μl, 5 μg/μl, and 15 μg/μl, implying that each 
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row will allow the hybridization of a different RNA substrate concentration.  
Therefore, the fluorescence concentration is expected to increase with primer 
concentration.  However, the signal intensity range does not change appreciably 
over all concentrations, and each row of the microarray will contribute cleavage 
data.  Each plot also shows an increase in the Cy3 signal over time, 
corresponding to the decrease in the Cy5 channel, and indicating the occurrence 
of a FRET event.  Therefore, we conclude that FRET can be measured indirectly 
by treating the microarray scanner data similarly to steady state assay data.  
However, we fist turn to using the capability of the microarray scanner to directly 
measuring the FRET signal. 
Figure 5.17 shows a data set for RC substrate hybridized to the 
microarray where the signal was measured in the Cy3, Cy5 and FRET channels.  
This data shows a decrease in the Cy5 channel and a slight increase in the Cy3 
channel over time due to disappearance of the acceptor fluorophore.  However, 
no change in the FRET channel is observed and any observed intensity is 
attributed to the expected 10% bleed-through of the Cy3 channel into the FRET 
channel.  It remains uncertain whether this effect is due to poor focusing or a 
malfunction of the microarray scanning equipment.  Therefore, FRET is indirectly 






Figure 5.16 Microarray data showing the Cy3 and Cy5 signal over time for the RC substrate 
hybridized to the spots of (a) 0.5 μg/μl, (b) 1.5 μg/μl, (c) 5.0 μg/μl, (d) 15.0 μg/μl, mRC primer.  An 
increase in the Cy3 signal is observed, corresponding to the decrease in the Cy5 channel, and 
indicating the occurrence of a FRET event.  The signal intensities slightly increase with primer 




Figure 5.17 Fluorescence signal intensity over time, measured in the Cy3 (green), Cy5 (red), and 
FRET (blue) channels.  The Cy5 signal decay is accompanied by a slight increase in the Cy5 
signal.  However, the signal in the FRET channel is constant and can be attributed to the 
expected 10% bleed-through of the Cy3 signal. 
5.3.2.2 Cleavable (RC) microarray data 
Cleavable RNA microarrays are incubated with an excess of HHT5 and 
either theophylline or caffeine.  The FRET ratio as a function of time is averaged 
over all spots in the microarray.  Error bars on the data are calculated based on 
the standard deviation of the FRET ratio values determined for each row of array 
data and may therefore be inflated.   
HHT5 is first incubated with 10mM theophylline and a cleavage rate of 
kobs = 1.6x10-3 ± 0.2x10-3 s-1 is calculated for this event, shown in Figure 5.18.  
As a control, HHT5 is incubated with 10mM caffeine and a cleavage rate of 
kobs = 1.1x10-3 ± 0.10x10-3 sec-1 is calculated from the single exponential fit in 
Figure 5.19.  It can be argued that the control data does not follow a single 
exponential fit but rather a linear decay.  However some background effects are 
observed due to either photobleaching or background cleavage.  However, a 
clear enhancement in the cleavage rate is observed for the target analyte over 





Figure 5.18 The average FRET ratio as a function of time calculated for hybridized cleavable 
RNA incubated with HHT5 and 10mM theophylline. A cleavage rate of kobs = 1.6x10-3 ± 0.2x10-3 s-
1 is calculated from the single-exponential fit. 
 
Figure 5.19 The average FRET ratio as a function of time calculated for hybridized cleavable 
RNA.  As a control, HHT5 is incubated with 10mM caffeine and a cleavage rate of kobs = 1.1x10-3 




Figure 5.20 The FRET ratio as a function of time calculated based on one spot of hybridized 
cleavable RNA.  HHT5 is incubated with 1mM theophylline and a cleavage rate of kobs = 1.3 x10-3 
± 0.4 x10-3 s-1 is calculated. 
 
Figure 5.21 The FRET ratio as a function of time calculated based on one spot of hybridized 
cleavable RNA.  HHT5 is incubated with 1mM caffeine and a cleavage rate of kobs = 0.8x10-3 ± 
0.3 x10-3 s-1 is calculated. 
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The experiment was repeated for a lower concentration (1mM) of both 
theophylline and caffeine.  The FRET ratio as a function of time calculated based 
on one spot of hybridized cleavable RNA is shown in Figure 5.20.  Here, HHT5 is 
incubated with 1mM theophylline and a cleavage rate of kobs = 1.3 x10-3 ±  
0.4 x10-3 s-1 is calculated for this event.  As a control, HHT5 is incubated with 
1mM caffeine and a cleavage rate of kobs = 0.8 x10-3 ± 0.3 x10-3 s-1 is calculated, 
resulting in a strikingly different kobs.  Therefore, at lower concentrations of 
theophylline, a clear increase in the cleavage rate is observed for the target 
analyte over that of the control.   
5.3.2.3 Non-cleavable (NC) microarray data 
To ensure the above trends are due to cleavage of the substrate, a control 
experiment is conducted using a single slide with non-cleavable RNA hybridized 
to both constellations.  The microarrays are incubated with either an excess of 
HHT5 or an excess of HHT5 plus theophylline.  Measurements are conducted by 
imaging the fluorescent signal in each channel for each constellation then 
alternating the constellation imaged.  The first constellation, shown in Figure 
5.22, is incubated with the excess HHT5 and 10mM theophylline solution.  No 
change in the average FRET ratio over time is observed.  Similarly, Figure 5.23 
also shows no change in the average FRET ratio over time for the non-cleavable 
RNA incubated with only HHT5.  The two figures, however, show an odd, almost 
direct, correlation between the FRET ratios.  This odd correlation is attributed to 
the equipment and may be due to inconsistent laser power or de-focusing over 
time.  Defocusing was observed later, in the GSI Lumonics ScanArray 5000, 
which allows the user to focus in each of the three measurement channels, as 
opposed to the PerkinElmer ScanArray Express model, which only allowed focus 





Figure 5.22 The average FRET ratio as a function of time calculated for hybridized non-cleavable 
RNA incubated with HHT5 and 10mM theophylline.  No change in the FRET ratio is observed. 
 
Figure 5.23 The average FRET ratio as a function of time calculated for hybridized cleavable 




5.3.2.4 Microarray experiment conclusions 
In conclusion, signal trends show that the biosensor is sensitive to 
theophylline concentrations down to 1 mM.  High specificity of the biosensor 
between theophylline and caffeine is also observed, indicating this is a feasible 
technology for the detection of theophylline.   
However, microarray scanner function and software is not designed to 
accommodate repeated, alternating measurements of multiple constellations.  
The inability for the scanner to maintain its focus after only a few minutes of 
measurement was not discovered until fairly recently.  This discovery forces us to 
refocus before each scan, a process that cannot be automated with the current 
software provided by the manufacturer.  The resulting loss of time resolution is 
also significant, as a data point can be acquired only every 90 sec, as opposed to 




CHAPTER 6  
OUTLOOK 
6.1 Microfluidics for Single-Molecule Experiments 
The eventual aim of this project is to incorporate the biosensor onto a 
stable and compact microfluidic platform that will allow for the analysis of 
extremely small sample volumes and the realization of an array of different 
sensor molecules that can detect a suite of target molecules of interest.  For 
single-molecule experiments, the chips can be fabricated using techniques 
currently in development by Meiners and coworkers [Che03, Che04a, Che04b] 
which closely follow those described by Unger, et al [Ung99] and Duffy, et. al. 
[Duf98].  The platform will take the form of a chip, manufactured in a multilayer 
soft lithography technique from a silicon elastomer and packaged in an epoxy 
casing to provide the mechanical stability for the chip to be plugged into a socket 
like an electronic chip Figure 6.1(d).  
The microfluidic chip will feature a hybridization spot to which the sensor 
molecules can be attached in-situ as well as reservoirs for sensor and reporter 
molecules Figure 6.1(a).  Microfabricated valves and pumps, created by 
overlapping channels separated by a thin membrane, will be incorporated into 
the chip to pneumatically control the flow of reagent and sample.  These 
channels work in such a way that when the control channel is not pressurized, 
the valve is open and flow through the flow channel is not impeded Figure 6.1(b).  
However, when the control channel is pneumatically pressurized, it expands and 




   
Figure 6.1  Microfabricated flow channels and pneumatically actuated valves. (a) Overview of a 
device with four supply and one exit channel converging in a reaction/detection area in the middle 
of the chip. Two pressure lines control the flow in each of the supply channels through a thin 
membrane. (b) Shows a close-up of an open valve, i.e., the intersection between pressure line 
and supply channel. In (c), the control line is pressurized and pinches the flow in the supply line 
off; the valve is closed. (d) Shows the assembled and packaged chip together with the external 
reagent delivery and pressure control system.  
More recently, a topologic structure was developed for microfluidic mixing 
[Che04a, Che04b].  This mixer exploits the laminarity of the flow to repeatedly 
fold the flow and exponentially increase the concentration gradients. Helical flow 
channels with opposite chiralities split, rotate, and recombine the fluid stream for 
fast and efficient mixing by diffusion.  The arrows in Figure 6.2(a) indicate the 
fluid flow split, rotation and recombination as two different solutions are combined 
in a T-junction.  This junction is created by overlapping and fusing together the 
two principal elastomer layers and anchoring with a third elastomer layer on a 
glass cover slip (Figure 6.2(b)).  The chip is then embedded in a block of epoxy 
resin for additional mechanical stability; steel tubes provide the inlets and outlet. 
Figure 6.2(c) shows the mixing of two fluorescently labeled protein solutions in a 






Figure 6.2 (a) Topologic structure for microfluidic mixing. Two different solutions are combined in 
a T-junction. The fluid flow is repeatedly split, rotated, and recombined as indicated by the arrows. 
(b) Schematic cross-section of an assembled mixing chip. The two principal elastomer layers are 
fused together and anchored with a third elastomer layer on a glass cover slip. The chip is 
embedded in a block of epoxy resin for additional mechanical stability; steel tubes provide the 
inlets and outlet. (c) Mixing of two fluorescently labeled protein solutions in a six-stage mixer at 
different flow rates.  Figure reproduced with permission [Che04b]. 
Microfluidic systems utilizing channels, mixers and various other 
components have become more popular in industry and academia in the past 
several years.  The ultimate goal of these devices is a lab-on-a-chip (LOC) that 
incorporates multiple aspects of laboratory work on a single microchip [Bee02]. 
6.2 Lab-on-a-chip prototypes 
The development of lab-on-a-chip (LOC) technologies are currently of 
significant interest in the scientific community as these devices integrate multiple 
laboratory functions on a small chip (of only a few square centimeters) and are 
capable of handling fluid volumes down to less than pico liters.  The discovery 
and development of microfluidic devices and their subsequent adaptability in 
various fields, ranging from Micro Electro Mechanical Systems (MEMS) to 
genomics and biological warfare defense, has fueled significant research in this 
area [Edw03]. 
LOC technologies, such as microfluidic biosensors are the focus of 
several research groups around the world.  Most notably, Zaytseva and 
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coworkers have developed microfluidic biosensors for the detection of 
pathogens, including the dengue virus [Zay05a, Zay05b]. 
LOC devices provide several advantages, in addition to their compactness 
and low fabrication costs.  Their low fluid volume consumption, due to the low 
internal chip volumes, lowers costs of expensive reagents as less sample fluid is 
used for diagnostics.  Short mixing times, as a result of the short diffusion 
distances, and fast heating due to high wall surface to fluid volume ratios and 
small heat capacities allow for higher analysis and control speeds.  LOCs afford 
better process control because of a faster response of the system and they are a 
safer platform for chemical, radioactive or biological studies because of the large 
integration of functionality and low stored fluid volumes and energies. 
These devices do possess several disadvantages due to their 
compactness.  For example, physical effects like capillary forces and chemical 
effects of channel surfaces become more dominant, making LOC systems 
behave differently and sometimes in more complex ways than conventional lab 
equipment. Also, detection principles may not always scale down in a positive 
way, leading to low signal-to-noise ratios.  As these technologies are novel, there 
is a considerable amount of research that can be done on the viability of this 














MFOLD SECONDARY STRUCTURE PREDICTION 
A.1 RNA Sequence Generation Techniques 
The following is a detailed description of the method used to generate two 
appropriate RNA substrate sequences for use in the biosensor experiment.  An 
appropriate sequence contains the sequence complementary to the HHT5 
hammerhead (5’- AUC CCG UCU GUU GUA C-3’ ) followed by a random “tail” 
sequence of 23 bases.  A primer for each substrate, complementary to the tail 
and composed of the random 23 base pair sequence, is also determined.  Both 
sequences and their primers must not dimerize (the hybridization of two identical 
molecules) or cross-hybridize (the hybridization of the substrates or primers to 
one another). Therefore, once sequences for RNA A and RNA B are generated, 
with primers DNA A and DNA B, respectively, they are tested for structure 
formation under the interaction conditions listed in Table A.1. 
 
Table A.1 Various interaction conditions tested to generate two suitable RNA sequences, A and 
B.  The sequences and their primers must not dimerize or cross-hybridize and show appropriate 
binding specificities.  “+” implies a non-binding spacer written as QQQ QQQ QQQ QQQ QQQ 
QQQ QQQ QQQ QQQ QQQ. 
+ RNA A RNA B DNA primer A DNA primer B 




RNA B  RNA dimerization 
Binding 
specificity N/A 
DNA primer A   DNA dim on  erizati
DNA cross-
hybridization
DNA pimer B    DNA dimerization 
 
To run the method, first download mfold onto an appropriate system 
[Zuk03].  Next, a series of files for testing in mfold must be generated by running 
evoltest.m in MatLab after changing any necessary parameters in the program.  
This program will call the function generate_sequences and analyze_data.  
Programs are compatible with MatLab version 6.5. 
As written, evoltest begins by generating 100 (this was increased to 1000 
later) random sequences containing 23 bases for the tail region of the RNA 
substate.  To check for interactions, its calls generate_sequences which will 
generate a batch of test sequences for each random sequence.  For each test 
sequence, mfold is run using analyze_data script, which collects relevant mfold 
output into a results file.  The simulation is run at at 22˚C with a 0.6 Na+2 
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concentration.  mfold generates a .ct file for each sequence it analyzes, fr
which the dG value and the number of bases involved in secondary structure 
formation (Nbases) can be extracted.  A matrix is then generated including the
sequence number, dG of most stable secondary structure generated for each 
test case, and Nbases.  For each sequence, search the matrix for the test case
with the smallest dG (worst loop) and sort using this parameter.  The best 15 
sequences (parent sequences) are chosen and considered “ok”. 













Table A.2 Sequences chosen for the RC and NC substrate and primer sequences. 
UA GU 
 to undergo mutation.  Sequences with a higher number of bases involved 
in loop formation are subsequently given a high chance for mutation.  Each 
sequence is checked for uniqueness and a random sequence is generated f
each non-unique sequence.   The sequences are then allowed to breed equally
Nbreed = 6 times.  This is done using a simple crossover technique where the 
first part of one sequence is joined to the second part of another sequence.  Th
105 new sequences are generated.  Of these, we take all unique sequences, 
adding random sequences to ensure there are at least 100 offspring.  These 
offspring undergo the same analysis as their parent sequences.   
The parent sequences undergo 20 iterations of evolution an
 the best sequences are manually chosen from the final results.  These 
sequences are manually tested using mfold and the process is repeated as 
necessary.  The mfold results for the test cases of the two sequences that ha
been selected for the RC and NC substrate sequence after five batch jobs were 
run starting with 999 random sequences are given in Table A.2.  Figure A.1 
shows the expected extent of dimerization of the two substrates, while Figure A.2
shows the expected extent of dimerization of their corresponding DNA primers.  
Figure A.3 (a) and (b) show the predicted lack of binding specificity of the RNA 
substrates to their non-corresponding DNA primer and Figure A.4 shows the 
expected cross-hybridization of the two substrates.  
 
RC sequence UAC CCG UCU GUU GUA C UC AUU CUA UCC UCC UUU CAC U
RC primer ACT AAG TGA AAG GAG GAT A 
N AAA AAA AAA AGC CGU AAA CU C sequence AUC CCG UCU GUU GUA C UC CCA 




Figure A.1 Secondary structure prediction generated by mfold showing the potential of self-
dimerization for (a) RC and (b) NC. 
 
 
Figure A.2 Secondary structure prediction generated by mfold showing the potential of self-










Figure A.4 Predicted cross-hybridization between (a) the RC DNA primer and NC RNA and (b) 
the NC DNA primer and RC RNA. 
A.2 Scripts and Functions 
A.2.1 Evolutionary Sequence Script evoltest.m 
%========================================================================= 







seqlen=23; % sequence length 
Nseq=100; % number of sequences to start with 
Nbest=15; % number of sequences to keep in each iteration 
Niter=20; % number of iterations to run 
Nbreed=6; % number of offsprings of each sequence 
Pmutate=0.02; % mutation likelihood (per base) 
Pnomut=(1-Pmutate)^seqlen; % chance of no mutation 
Ntests=5; % how many tests per sequence   NOTE: determined by generate_sequences! 
  
no_loop_value=+42; % energy assigned if there is no looping at all 
 
dna_complement('A')='T';dna_complement('U')='A'; dna_complement('Q')='Q';  
dna_complement('C')='G';dna_complement('G')='C'; 
  






    seq_b=rna_bases(ceil(4*rand(1,seqlen))); 




    sequences=generate_sequences(seq_b); 
    Ntests=length(sequences); 
     
    for i2=1:Ntests 
        mkdir(sprintf('batch%02d',i2)); 
        fid=fopen(sprintf('batch%02d/seq_%04d_%c.seq', i2, i1, '@'+i2),'wt'); 
        fprintf(fid,'%s',sequences{i2}); 
        fclose(fid); 
    end % for i2 




%% run analysis 
for i1=1:Ntests 
    [in, out, thispid]=popen2('./analyze_data',sprintf('batch%02d',i1)); 
    pid(i1)=thispid; 
    % start parallel analysis, only works in linux (octave) 
end % for i1 
for i1=1:Ntests 
    waitpid(pid(i1)); % wait for analysis to finish 
%   pclose(pid(i1)); 








    fid=fopen(sprintf('batch%02d/results',i1)); 
    fid2=fopen(sprintf('batch%02d/results_bound',i1)); 
    res=[]; file_no=[]; b_res=[] 
    while ~feof(fid) 
        s=fgetl(fid); s2=fgetl(fid2); 
        if length(s)>1 
            res=[res;str2double(s(12:22))]; 
            file_no=[file_no;str2double(s(27:30))]; 
            b_res=[b_res; (s2((end-seqlen+1):end)=='X')]; 
  
            % read dG and file number (4 digits) 
            % as well as which bases were involved in a structure 
        end % if length 
    end % while not EOF 
    fclose(fid); fclose(fid2); 
  
    for i2=1:length(curr_SEQ) 
        ind=find(file_no==i2); 
        if (length(ind)) 
            run_results(i2,i1)=min(res(ind)); 
            % the smaller, the better binding 
            % so we are selecting the 'worst' case 
            bound_res(i2,:)=sum(b_res(ind,:)); 
        else 
            run_results(i2,i1)=no_loop_value;            
        end % if length 
    end % for i2 
end % for i1  
     
total_results=min(run_results')';   % the 'worst' of all tests 
  
fid_res=fopen('results','wt'); 
fprintf(fid_res,'** results of sequence evolution\n\n'); 














    fprintf(fid_res,'\t\t%3d: %s (%.2f)\n',i1,char(old_SEQ{i1}),total_results(i1)); 







    system('rm -rf batch??/*');     % clear last results 
     
    fid_thisiter=fopen(sprintf('results_%03d',i_iter),'wt');  
  
    %% winning sequence has a second go 
    curr_SEQ=old_SEQ; 
  
    %% but it mutates 
    Nmut=0; 
    Mutate=rand(length(curr_SEQ),1); 
    index=find(Mutate<(Pnomut.*(sum(bound_res')'+1))); 
        % the more bases forming structures, the more mutation 
  
    for i1=1:length(index) 
        index2=find(rand(seqlen,1)<(Pmutate.*(bound_res(i1,:)'+1))); 
        Nmut=Nmut+length(index2); 
        if (length(index2)>0) 
            seq=curr_SEQ{index(i1)}; 
            seq(index2)=rna_bases(ceil(4*rand(1,length(index2)))); 
            curr_SEQ{index(i1)}=seq; 
        end % if sum 
    end % for i1 
  
    curr_SEQ=unique(curr_SEQ); 
    oldsize=length(curr_SEQ); 
    newsize=oldsize+oldsize*Nbreed;     % number of new sequences 
    N=length(curr_SEQ)+1; curr_SEQ{newsize}={}; 
        % copy and pre-allocate memory 
        % make sure we don't have too much incest 
  
    %% 'breeding' of sequences (crossover) 
    disp(sprintf('\n\n***\niteration: \t %3d\nnew size:\t%3d\n***\n\n',i_iter,newsize)) 
    fprintf(fid_thisiter,'iteration:\t%3d\ninput size:\t%3d\n',i_iter, oldsize); 
    fflush(fid_thisiter); 
  
    for i1=1:oldsize 
        index=ceil(oldsize*rand(1,Nbreed)); % randomly chose Nbreed 
  
        seq1=curr_SEQ{i1}; 
        for i2=1:Nbreed 
            X=round(seqlen/10*randn+seqlen/2);  % where is the cross-over 
            if X<2, X=2; end 
            if X>(seqlen-2), X=seqlen-2; end 
  
            if (rand(1)>0.5) 
                curr_SEQ{N}=char([seq1(1:X), curr_SEQ{index(i2)}((X+1):end)]); 
            else 
                curr_SEQ{N}=char([curr_SEQ{index(i2)}(1:X), seq1((X+1):end)]); 
            end % if rand 
            N=N+1; 
        end % for i2 
    end % for i1 
     
    curr_SEQ=unique(curr_SEQ);  % don't run on identical sequences 
    N=length(curr_SEQ)+1; 
  
    %% add new ones if necessary 
    if (length(curr_SEQ)<Nseq) 
        Nmissing=Nseq-length(curr_SEQ); 
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        for i1=1:Nmissing 
            curr_SEQ{N}=rna_bases(ceil(4*rand(1,seqlen))); 
            N=N+1;  % new random sequence 
        end % for i1 
    else 
        Nmissing=0; 
    end % if (N<Nseq) 
  
    fprintf(fid_res,'Run: %3d\n\tsequences:\t%d\n',i_iter,length(curr_SEQ)); 
    fprintf(fid_res,'\t\t(%d new, %3d mutations)\n',Nmissing, Nmut); 
  
    fprintf(fid_thisiter,'sequences:\t%3d\nmutations:\t%d\n',length(curr_SEQ),Nmut); 
    fflush(fid_thisiter); fflush(fid_res); 
     
    for i1=1:length(curr_SEQ) 
  
        seq_b=curr_SEQ{i1}; 
        sequences=generate_sequences(seq_b); 
  
        for i2=1:Ntests 
            fid=fopen(sprintf('batch%02d/seq_%04d_%c.seq', i2, i1, '@'+i2),'wt'); 
            fprintf(fid,'%s',sequences{i2}); 
            fclose(fid); 
        end % for i2 
    end % for i1 
  
    clear pid; 
    %% run analysis 
    for i1=1:Ntests 
        [in, out, thispid]=popen2('./analyze_data',sprintf('batch%02d',i1)); 
        pid(i1)=thispid; 
        % start parallel analysis, only works in linux (octave) 
    end % for i1 
    for i1=1:Ntests 
        waitpid(pid(i1));   % wait for analysis to finish 
    %   pclose(pid(i1)); 
    end % for i1 
  
    clear run_best; 
  
    run_results=zeros(length(curr_SEQ),Ntests); 
    bound_res=zeros(length(curr_SEQ),seqlen); 
  
    for i1=1:Ntests 
        fid=fopen(sprintf('batch%02d/results',i1)); 
        fid2=fopen(sprintf('batch%02d/results_bound',i1)); 
        res=[]; file_no=[]; b_res=[]; 
        while ~feof(fid) 
            s=fgetl(fid); s2=fgetl(fid2); 
            if length(s)>1 
                res=[res;str2double(s(12:22))]; 
                file_no=[file_no;str2double(s(27:30))]; 
                if (length(s2)>0) 
                    b_res=[b_res; (s2((end-seqlen+1):end)=='X')]; 
                else 
                    b_res=[b_res; zeros(1,seqlen)]; 
                end % if length s2 
                % read dG and file number (4 digits) 
                % as well as which bases were forming structures 
            end % if length 
        end % while not EOF 
        fclose(fid); fclose(fid2); 
  
        for i2=1:length(curr_SEQ) 
            ind=find(file_no==i2); 
            if (length(ind)) 
                run_results(i2,i1)=min(res(ind)); 
                bound_res(i2,:)=sum(b_res(ind,:)); 
                % the smaller, the better binding 
                % so we are selecting the 'worst' case 
            else 
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                run_results(i2,i1)=no_loop_value;            
            end % if length 
        end % for i2 
    end % for i1  
     
    total_results=min(run_results')';   % the 'worst' of all tests 
  
    [total_results,ind]=sort(total_results,'descend'); 
    cutoff_val=total_results(Nbest); 
    ind2=(total_results>=cutoff_val); 
  
    fprintf(fid_res,'\t surviving sequences (%d, dG >= %5.2f)\n',sum(ind2),cutoff_val); 
    fprintf(fid_thisiter,'surviving sequences (%d, dG >= %5.2f)\n',sum(ind2),cutoff_val); 
  
    old_SEQ=curr_SEQ(ind(ind2)); 
    bound_res=bound_res(ind(ind2),:); 
  
    for i1=1:sum(ind2) 
        fprintf(fid_res,'\t\t%3d: %s (%.2f)\n',i1,char(old_SEQ{i1}),total_results(i1)); 
        fprintf(fid_thisiter,'\t\t%3d: 
%s(%.2f)\n',i1,char(old_SEQ{i1}),total_results(i1)); 
    end % for i1 
  
    fprintf(fid_res,'\n'); 
    fflush(fid_res); 
    fclose(fid_thisiter); 
  




%% End evoltest script 
 
A.2.2 Function generate_sequences.m 
%========================================================================= 
% Written by Gerhard A Blab & K Jordan 
%========================================================================= 
 








    seqlen=19; 
elseif (isempty(seqlen)) 
    seqlen=19; 
end % if isempty seqlen 
if (nargin<1)  
    seq_target=rna_bases(ceil(4*rand(1,seqlen))); 
elseif (isempty(seq_target)) 
    seq_target=rna_bases(ceil(4*rand(1,seqlen))); 
end % if isempty seq_target 
  
seq_a_star='AUUCUAUCCUCCUUUCACUUAGU'; % found by trial (no binding to hammerhead) 
seq_A=fliplr(dna_complement(seq_a_star)); % old DNA primer, v2 
 
old RNA sequence 
seq_hammer='AUCCCGUCUGUUGUAUYY'; % new RNA minus complement for B (19 bases) 
seq_a=[seq_hammer,seq_a_star]; 
fillersequence=char('Q'*ones(1,25)); % spacer with non-base-forming elements 
  
seq_B=fliplr(dna_complement(seq_target)); %  DNA complement of attachment 
seq_b=[seq_hammer,seq_target]; %  generate full RNA strand (hammer head + attachment) 
seq_b_dimer=[seq_b,fillersequence,seq_b]; % must not form homogenous dimers 
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seq_B_dimer=[seq_B,fillersequence,seq_B]; % ditto 
seq_ab_cross=[seq_a,fillersequence,seq_b];% RNAs must not crosslink 
seq_Ab_cross=[seq_A,fillersequence,seq_b];% RNA b must not attach to DNA A 








A.2.3 Script: analyze_data  
The following script calls on mfold to predict the secondary structure of the 
generated sequences at T=22˚C and 0.6 mM Na2+ concentration.  All other 
conditions are left to default, but can be changed by modifying this script.  This 
script copies out all of the dG values determined for the various sequences 
tested in mfold and saves to a results file.  All mfold output .pdf files are then 









#if [-e results ;] then 
        rm -rf results* pdfs 
#end 
mkdir pdfs 
for i in *seq; do 
        j=`basename $i .seq` 
        mfold SEQ=${i} T=22 NA_CONC=0.6 &>/dev/null 
        for k in *ct; do 
                head --lines=1 $k >> results 
  while read -r dummy dummy dummy dummy bound dummy; do  
   if [ ${bound:0:3} != 'seq' ]; then 
    if [ $bound -gt 0 ]; then 
     echo -n X >> results_bound 
    else 
     echo -n O >> results_bound 
    fi 
   fi  
  done < $k                 
  echo >> results_bound 
        done 
        mv $i done_$i 
 mv $j*pdf pdfs/ 




A.2.4 Sequence Generator for Manual mfold Testing 
%========================================================================= 
% Program to generate files for MFOLD to analyze from "best" linker regions 
% as determined by evoltest.m (run 05/16/06) 
%  





ORS = 'UACCCGUCUGUUGUAUUCAUUCUAUCCUCCUUUCACUUAGU'; %Old RNA Sequence 
OD = 'ACTAAGTGAAAGGAGGATA'; %Old DNA Sequence 
R = 'AUCCCGUCUGUUGUAUYY'; %Region complementary to HHT5 
x = 'QQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ'; %Spacer 
  
bases = 'UAGC'; N = 19; 
compl('A')='T'; compl('U')='A';compl('C')='G';compl('G')='C'; 
  
NLR = 'CCAAAAAAAAAAAGCCGUAAACU'; %New linker region to test 
%  NLR = 'CCAAAAAAAAAAAGCCGUAAAUU'; 
 
ND = fliplr(compl(NLR)); %New DNA primer 
  
% Generate the sequence combinations to test 
A = [R,NLR,x,R,NLR]; 
B = [R,NLR,x,OD]; 
C = [ORS,x,R,NLR]; 
D = [ORS,x,ND]; 
E = [ND,x,ND]; 
  
filename_A = sprintf('sequence_1_A.seq',i); 
filename_B = sprintf('sequence_1_B.seq',i); 
filename_C = sprintf('sequence_1_C.seq',i); 
filename_D = sprintf('sequence_1_D.seq',i); 
filename_E = sprintf('sequence_1_E.seq',i); 
  
% Open file for each sequence 
fidA = fopen(filename_A,'w'); 
fidB = fopen(filename_B,'w'); 
fidC = fopen(filename_C,'w'); 
fidD = fopen(filename_D,'w'); 
fidE = fopen(filename_E,'w'); 
  





















B.1 Labeling Modified RNA 
For fluorophore-labeled RNA, take care to work in the dark (keep tubes 
wrapped in foil) as much as possible.  This will limit the amount of 
photobleaching that can occur during the preparation stage.  Also, store RNA in 
the -80˚C freezer.  This will also increase its shelf-life. 
B.1.1 RNA Deprotection 
1) Add 800μl triethylamine trihydrofluoride (TEA 3HF) and 200μl dimethyl 
formamide (DMF).  Vortex.   
Shake at RT for 20-24hours. 2) 
3) Quench reaction with 200μl ddH2O. 
4) Transfer to Falcon tube and add 5ml 1-butanol.  Mix and chill the solution at -
80˚C for at least 45min.  This can safely be left overnight. 
Centrifuge at 3000rpm for 10min. Decant. 5) 
6) Dry RNA in SpeedVac, taking care to not dry out too much. 
 
B.1.2 15% Polyacrylamide Gel Electrophoresis 
Next, the RNA must be gel purified.  The following protocol includes steps 
for both analytical and purification gel electrophoresis. 
 
1) Set up gel plates (use the short plates for analytical gel and long plates for 
purification). 
Add: 2) 
 15% Gel 20% Gel 
 Analytical Purification Analytical Purification 
Urea 24.0 g 48.0 g 24.0 g 48.0 g 
40% Acrylamide 18.75 ml 37.50 ml 25.0 ml 50.0 ml 
5xTBE 16.25 ml 32.5 ml 10.0 ml 20.0 ml 
 
3) Microwave 20 sec.  Stir until dissolved and cooled.   
4) Add 90μl each 50% APS and TEMED for analytical gel, 130 μl each for a gel 
purification. 
Pour gel MM5) EDIATELY and let set. 
6) Re-suspend RNA in ddH2O and determine concentration. 
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7) For an analytical gel, extract 4μg into eppendorf tube.  For purification, take 
W for 
lume of appropriate dye.  For the analytical gel, use FA-LB + 
 
as to 
ce bath 10min. 
til there is sufficient dye 
gel. 
:  Leave gel in Ethinium Bromide solution 10-15min.  
the 
s under UV light source.  Photograph. 
B.1.3 RNA Extraction Post Gel Purification 
1) Cut out RNA band from gel.  Chop and load into column.  Fill with 4-6ml 1mM 
of bottom chloroform layer.  Mix. Centrifuge at 9000rpm 
ernatant (top layer). 
me of 3M NaOAc (Sodium Acetate) 
 (can sit overnight).  Centrifuge tubes at 
B.1.4 HPLC Purification 
1) Re-suspend RNA in about 105μl.  Only 100μl can be loaded into the HPLC 
 HPLC logbook. 
ot full and that there is plenty of Buffers A 
on the 
computer. 
half of the RNA stock.  Dry down excess and store in the -70°C. 
8) Set up the gel, remembering to pre-run (at 25W for analytical, 45
purification). 
9) Add equal vo
BPB + XC.  This will give Bromophenol Blue (at about 8 bases for 20% gel)
and Xylene Cyanol (at about 38 bases for 20% gel) bands.  For the gel 
purification, use FA-LB +BPB, that only contains Bromophenol Blue, so 
not contaminate the RNA with dye. 
10) Place in 90°C heat bath 2 min then i
11) Load RNA onto gel.  Cover.  Let run 1-2 hours (or un
separation). 
12) Disassemble 
13) For analytical only
Recycle Ethinium Bromide.  Wash.  Leave in water 15-20min to quench 
reaction.   
14) View result
EDTA.  Use just enough buffer to cover the gel bits.  Tumble at 4°C overnight. 
2) Extract buffer into Falcon tubes. 
3) Chloroform Extract:   
a) Add equal volume 
5-10min.  
b) Extract sup
c) Add about 5μl of 100mM ATP 
4) Ethanol Precipitate: 
a) Add 10% total volu
b) Add 3x volume cold Ethanol.   
c) Leave in -70°C at least 3 hours
9000rpm for 20 min.  Pipette off EtOH. 
5) Dry down pellet(s) and store in -70°C. 
for purification.  The excess 5μl should be extracted and diluted in ddH2O to 
total volume of 100μl and injected for the analytical run. 
2) Start up HPLC: 
a) Make entry in
b) Check the waste container is n
and B.  Also check that Buffer A is free from contamination. 
c) Turn on the power strip behind the instrument and then turn 
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om the release valve) and continue flow until the bubbles disappear 
y for 
our method/gradient from the file menu (C8 for Cy5+3 or 
ient or C18 for long_doubly_labeled_RNA work well 
ftware. 
e “Load” position. 
ing your sample 




ytical run, determine the peak(s) 
 
pected 
orf tubes, if not already done.  
 serpentine. 
c,  
 divert,  
ver the “A” button before loading the 
 put 
ion valve in the “Load” position. 
e) Ramp the pumps to 50% B at 6ml/min over 1 min ramp.  Watch the pum
line (fr
(takes about 5 min and the bubbles never totally disappear). 
f) Ramp the pumps to 100% B at 3ml/min over 1 min for about 30 sec. 
g) Stop the pumps and close the release valve. 
3) Run the method STARTUP (run time is 31min).  The column is now read
an injection. 
4) To run a sample: 
a) Activate y
reallyslowGrad
depending on which column, C8 or C18 is in use). 
b) First do an analytical run: 
c) Click the “Run” command in the system control so
d) Put the injection valve in th
e) Clean the injection syringe with ddH2O 4 times before load
f) Load sample, injecting syringe until you feel th
valve to “Inject” 
g) Clean the injection syringe and the injection valve (while still in the “Injec
position) with dd
h) Wait 80min for the method to finish. This is a good time to load the fraction 
collector for the prepara
5) Wait 10min between multiple runs to ensure system returns to initial state. 
6) From the graph output from the anal
corresponding to the RNA and calculate the appropriate collection time and
number of fractions to collect.  (A 42-mer singly labeled with Cy5 is ex
around 30min, while a doubly labeled 42-mer is expected around 32min.  
Collection between 26min and 34:16min in 24 fractions (20 sec each fraction 
and a 16 sec delay) should be sufficient.) 
7) The preparative run (the purification run): 
a) Load the fraction collector with eppend
Remember that the collection pattern is
b) Program the fraction collector: 
i) Type = time windows,  
ii) Rack Type = microtubes,  
iii) Pattern = standard,  
iv) Fraction by time,  
v) Fraction = 20sec,  
vi) Flow Delay = 16se
vii) Nonpeak/Window =
viii)Restart = none. 
c) The window should show RUN o
sample. 




e) Load sample, injecting syringe until you feel the second stop.  Turn the 
valve to “Inject”.  Simultaneously hit “Start” on the fraction collector. 
t” 
ensure system returns to initial state. 
gbook entry 
e 
hen the column is under pressure. 
 
2) Ethanol precipitate. 
ost HPLC Purification 
inimidyl ester (Cy3 Mono-Reactive 
k) 
 containing up to 100μg oligonucleotide 
 Protocol 
work with than RNA.  It can be stored at -20°C and 
does not need to be dried.  There is also no deprotection protocol to be followed 
here.  
bel): 
a) ote that NAP-5 or NAP-10 is prepackaged Sephadex G-25 column (5ml 
ange.  
 1ml of buffer of interest or water and collect (for NAP-10 use 
e) Recover column by rinsing with 5 column volumes of buffer/ddH2O. 
f) Clean the injection syringe and the injection valve (while still in the “Injec
position) with ddH2O.  
g) Wait 80min for the method to finish, collecting fractions when necessary. 
8) Wait 10min between multiple runs to 
9) To shut down the HPLC: 
a) Activate and run the method SHUTDOWN.  This will take 21min. 
b) Complete the HPLC lo
c) Shut down the computer, and then flip off the power strip behind th
instrument. 
d) DO NOT open the release valve. 
10) NEVER open the release valve w
B.1.5 Removal of Triethylamine from HPLC Purification Pre Labeling
1) Dissolve RNA in 100μl ddH2O and chloroform extract one to two times. 
3) Dry in speedvac   
 
B.1.6 Cy3 Labeling P
1) Combine: 
a) 14μl DMSO, containing 200μg dye succ
dye pac
b) 75μl 0.1M Na2B4O7-HCl, pH 8.5 (or 10μl 1M NaHCO3/NaCO3-, pH 8.3) 
c) 11μl ddH2O
d) Fill with ddH2O to total volume of 100μl. 
2) Incubate at RT in the dark overnight or for 16 hours. 
3) EtOH precipitate. 
4) HPLC purify. 
B.2 Modified DNA
DNA is much easier to 
However, the DNA must be desalted before use. 
 
1) Desalt using a NAP-10 column (DNA with a 5’ Cy3 la
N
bed volume) from Pharmacia for desalting and buffer ch
b) Rinse with 5 column volumes of buffer of interest (for desalting use 
ddH2O) 





2) For 5’ biotinolated DNA, dissolve in ddH2O. 
3) Measure the concentration. 
4) Run an analytical gel to check purity.  Most likely the gel will not show 
degradation so purification (gel and HPLC) will not be necessary. 
1) Prepare the reaction solutions: 




oncentrated top and bottom strands  
t bath for 3min then cool on ice. 
each 100mM ATP, UTP, CTP, GTP 
/μl (Pyrophosphatase inorganic)  
.5mg/ml) 
vernight) 
in the -20˚C overnight.) 
tube 
s 
 column 3000 – this will take 2-4 hours  
volume is low enough to load on a gel 
 
s with BPB+XC and run at 25W 
B.3 In Vitro Transcription Protocol for HHT5 Hammerhead 
a) 4X Reaction Buffer (total V=2500μl): 
ii) 300μl 1M MgCl2 
iii) 20μl 1M Spermidine 
iv) 400μl 1M DTT 
v) 100μl 1% Triton X
vi) 480μl ddH20 
b) Reaction Solution (
i) 131.25μl ddH2O 
ii) 375μl 4X Rea
iii) 300μl 40% PEG 
iv) 150μl each 3μM c
2) Heat reaction solution in 90˚C hea
3) Combine: 
a) 66.25 μl ddH2O 
b) 1106.25 μl of reaction solution 
c) 60 μl of 
d) 37.5 μl PPi 0.1 u
e) 50 μl T7 Polymerase (T7 His) 0
4) Heat for at least 3 hours at 37˚C (This can stay o
5) Add 160μl 0.5M EDTA to stop reaction (This can stay 
6) Phenol/Chloroform extract: 
a) Add 1.5ml phenol/chloroform 
b) Vortex then centrifuge for 15min 
c) Transfer top layer to new 
d) Add 1.5ml chloroform 
e) Vortex then spin to separate layer
f) Transfer top layer to new tube 
7) Concentrate with centricon
a) Centrifuge 4000-6500G at 4˚C until 
(200-400μl) 
b) For ~2min at 300-1000G at 4C to collect RNA/DNA into the cap
8) Prepare and run (small) 20% denaturing gel to separate full transcripts: 
a) Load sample
b) Allow XC to run to the bottom of the gel (2-3 hours) 
9) Recover the transcribed RNA: 
a) Tumble in 1mM EDTA 
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b) Chloroform extract with 3ml chloroform twice 
c) EtOH precipitate 
d) Dry and resuspend in ddH2O 
 for Single-Molecule TIR-FRET Experiments 
1) Buffers needed: 
i) 50 mM Tris-HCl pH 7.5 
l2 
ose (Glucose Buffer): 
l pH 7.5 
ter 
l pH 7.5 
er System (OSS): 
t volume Glucose Oxydase 
 Tris-HCl and 50 mM NaCl, pH 7.5 
ette (do not shake) and do not to introduce air 
 
eta-mercapto-ethanol)  
s to the appropriate size 
re to remove pipette tip without 
to the channel. 
 let sit for 5min. 
 30sec 
n. 
h a drop of ddH O and wait 5 min. 
 5 nM solution (Solution B): 
B.4 Sample Preparation
a) Standard Buffer: 
ii) 20 mM MgC
iii) dilute to 10ml  
b) Standard Buffer + 10%Gluc
i) 50 mM Tris-HC
ii) 10 mM MgCl2 
iii) 1 g Dextrose 
iv) dilute to 10ml & sterile fil
c) Sodium Buffer: 
i) 50 mM Tris-HC
ii) 200 mM NaCl 
d) Oxygen Scaveng
i) 12.5 μl Catalase 
ii) 50 μl equivalen
iii) 100μl of Buffer containing 50 mM
iv) Mix lightly with pip
bubbles 
e) OSS Buffer: 
i) 192 μl Glucose Buffer 
ii) 2 μl OSS
iii) 4 μl βME (B
2) Slide Preparation: 
a) Cut pipette tip
b) Pipette 50μl BSA into channel.  Take ca
introducing air in
c) Seal each hole with drop of ddH2O and
d) In the meantime, prepare Solution A: 
i) 1 μl R_Cy3_Cy5 
ii) 0.411 μl D_19_B 
iii) 7.60 μl Standard Buffer 
iv) 1 μl βME 
e) Let sit in 90C bath for
f) Let cool to RT for about 5mi
g) Inject: 
i) ~80 μl Sodium buffer 
ii) ~80 μl Streptavidin 
h) Seal wit 2
i) In the meantime, prepare
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i) 2 μl Solution A 
ii) 4 μl βME 
iii) 194 μl Standard Buffer 
3) Set up calibration laser as per Walter Lab protocol 
lution (Solution C): 
tion C 
ments as per Walter Lab protocol 
cluding injection of analyte 
as per current Walter Lab protocols. 
:   
 
4) Prepare 100 pM so
i) 4 μl Solution B 
ii) 4 μl βME 
iii) 192 μl Standard Buffer 
5) Inject slide with ~80 μl Standard Buffer and let sit 
6) Inject ~80 μl Solu
7) Start single molecule measure
8) Inject ~100 μl Ribozyme Buffer (OSS+Rz): 
i) 250 nM HHT5 
ii) Fill to 100 μl with OSS Buffer 
9) Continue single molecule measurements, in
buffer(s) and analyze 
B.5 Spectrophotometer Calculations 
To determine the concentration of an oligo, specifically of a 1/100 dilution 
of RNA, the following equations are used





= ×  (5.5) 
where c’ = concentration of RNA (μg/μL), c = molar concentration of RNA (μM), A 
= (abs bance at 260 nm – absorbance at 320 
average molecular weight of base, and 3.7 = estimated multiplier for RNA (for 
 
or nm), n = number of bases, 330 = 
single-stranded DNA, use 4.0). 




= ×  (5.6) A
where  = Concentration of fluorophore (M), A = Absorbance (at 550 nm for Cy3 
and at 650 nm for Cy5), ε = Molar extinction co
and 250000 /M/cm at 650 nm), and b = Path length, known to be 1 cm. 
m slide using 8 quills.  For 
one constellation, only one quill is necessary.   
 
1) Using a 384 well plate, fill the wells with 3µl of oligo/spotting solution.   
c
efficient (150000 /M/cm at 550 nm 
B.6 Preparation of Slides for Microarray Printing 
The spotter uses split quills to print the slides.  Up to 8 constellations 




1, C2, D1, D2, C13, C14, D13, 
D14, E1, E2, etc...    
, A15, A16...etc. 
A17, A18...etc. 
3) functionality with the printer, thus, for 
e in the 384 well plate.   
Initial Composition 
 printing order is as follows: 
a) For the first quill (or one quill): 
i) A1, A2, B1, B2, A13, A14, B13, B14, C
b) For the remaining quills, just shift over: 
i) For quill 2:  A3, A4, B3, B4
ii) For quill 3:  A5, A6, B5, B6, 
iii) For quill 4:  A7, A8, B7, B8, A19, A20...etc. 
Unfortunately, there is no repeat type 
every repeated spot, you will need 3μl volum
B.7 Microarray Sample Preparation Protocol 
1) First, ensure the following buffers are available.  
  
a) Buffer A (Blocking Buffer): 
Final Composition Volume  
5X SSC 1.25 ml 20X SSC 
0.5% SDS 0.05 ml 10% SDS 
0.1 mM EDTA 1.0 ml 10 mM EDTA 
1% BSA 0.05 g BSA 
Fill to 5ml ddH O Fill2  to 5.0 ml ddH2O 
 
b) Buffer C (Hybridization Bu
osition Vo dd position 
ffer): 
lu aFinal Comp me to Initial Com
50% formamide 40 ul formamide 
5X SSC 20 ul 20X SS C 
0.1% SDS 0.8 ul 10% SDS 
1/40 herring sperm DNA 2.0 ul herring sperm DNA 
1/10 RNA substrate 8.0 ul RNA substrate 
Fill 2to 90ul ddH O 19.2 ul ddH2O 
 
c) Wash Buffers: 
ition 20X SSC 10% SD inal V Buffer Compos S ddH2O F
I 1X SSC 0.2% SDS 1 400 ul .0 ml 18.6 ml 20 ml 
II 0.1X SSC 0.2% SDS 400 ul 20 ml 100 ul 19.5 ml 
III 0.1X SSC 0 .9 ml 20 ml 100 ul 19
IV ddH2O 0 0 20 ml 20 ml 
 
2 a tampe or (~3
3) cuba for 30
4) bel slides to be us  diamo  knife, ly in g 
atio onstellations to be ed as the ill no l be v post-
blocking. 
d constellations. 
tep (~10 min) 
) repP re Buffer A and s d  f slides  b g lockin 0 min) 
In te Buffer A at 42˚ min 
La stamped ed with nd  careful dicatin
loc ns of c us y w onger isible 
5) Place hybridization (HybriWell or homemade) chamber aroun
6) Blocking (~30 min) 
a) Spot Buffer A onto constellations, cover with coverslip. 




a) Place slides in Coplin jar filled with H2O and shake for 1-2 min. 
b) Repeat 4 times. 
c) Place slides in Coplin jar filled with isopropanol and shake for 1-2 min. 
ed up process). 
(~5 min) 
d place 
ions (this is to hold hybridization buffer in place and 
id that 
nment at RT for hybridization time 
ation time: 6 hours 
NA hybridization time: 1.5 hours 
C 
ll using parafilm 
 ensure it is hyrophyllic 




g and calibrating, increase to 10μm 
 ensure signal is not saturated 
This protocol calls for a 10:1 ratio of A:B where A is PDMS (RTV615A) 
and B is the curing agent (RTV615B).  This ratio can be varied from 10:1 to 10:4 
8) Let slides air dry (Can lightly flow air over slides to spe
9) Prepare for hybridization 
a) Make small hybridization chambers out of double-sided taped an
around constellat
isolate the constellations for the duration of hybridization). 
10) Add DNA and RNA to Buffer C as appropriate 
11) Heat Buffer C to 90˚C for 2 min 
12) Cool on ice for ~ 30 sec. 
13) Hybridization 
a) Spot Buffer C as appropriate, ensuring there is enough liqu
evaporation will not be a problem. 
b) Let sit in a dark, humid enviro
i) RNA-DNA hybridiz
ii) DNA-D
14) Post-hybridization (~30 min) 
a) Leave coverslips in wash buffers I, II, III, and IV for 5 min each while 
agitating. 
b) Dry slides and store in dark slide box in 4˚
15) Create flow cell around constellations 
a) Cut out pattern for flow ce
b) Cover with a coverslip that has been washed (and plasma cleaned – 
optional) to
c) Use a soldering iron to melt the parafilm, sec
16) Introduce appropriate measurement bu
a) Standard buffer + HHT5 hammerhead (+ th
17) Close off inlet and outlet of flow cell using vacuum grease to ensure 
experimental conditions do not change durin
18) Image slides using microarray scanner  
a) Appropriate starting settings: 
i) Focus: -50 
ii) PMT gain: 80% 
iii) Power: 75% 
iv) Resolution:  use 50μm for focusin
to take data 




B.8 Spin Coating a 30μm Layer of PDMS Onto a Coverslip 
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depending on the layer properties desired.  These volumes yiel
2
d approximately 
16 coated 18mm  coverslips. 
c) dd 1g of B (for a 10:1 ratio).  Mix well with stir stick. 
t overflow. Do not degas for 
tart to set. 
l, large bubbles will form.  If this happens, let off on the 
op, then  turn the 
lines. 
 
r 3 times for several seconds to warm it up. 
amber and allow to come to equilibrium 
lade or scalpel to cut desired channels into PDMS. 
 near the center of the coverslips is 
hickness 
exploit this 
and use it as a lifterslip.  
S spin-coated slides will be hydrophobic and slides 
must be plasma cleaned before use in a fluid environment.  The following is the 
2G Basic Plasma Cleaner (does not include 
the PlasmaFlo Gas Flow Mixer).  If the unit has not been in use recently, 
moistu
ing 
b) ash thoroughly with isopropanol. 
.  Attach vacuum line and make sure vacuum 
n for approximately 45 min. 
 
1) Weigh out materials as follows and mix well: 
a) Pour 10g of A into a weighboat 
b) Zero scale 
A
2) Degas the mixture, being careful to not to let i
more than 45min or the PDMS will s
3) If mixed too wel
vacuum and lightly shake the chamber until the bubbles p
vacuum back on. 
4) Make sure the oven is on at 80˚C. 
5) When bubbles are mostly gone, close chamber valve and remove from 
6) Ensure spin coater vacuum lines are open before turning on the spin coater.
Run the spin coate
7) Slowly release valve on vacuum ch
8) Center the coverslip on the peg, deposit a drop of PDMS mixture onto the 
coverslip and start spin cycle, using Recipe 1 settings for a 30μm layer. 
9) Recipe 1: 
a) 10 sec at 500rpm to spread out the PDMS 
b) ~45 sec at 2000rpm to spin it down 
10) Leave coated coverslips in oven for approximately 30 min to cure. 
11) Use razor b
 
Note that the thickness of the PDMS
approximately 30μm but along the edges, there is a raised lip and the t
is about 60-120μm.  Normally, this raised area can be cut off, but I 
B.9 Plasma Cleaning of Coverslip 
The surface of PDM
protocol used with the Harrick PDC-3
re and air contaminants may accumulate in the chamber, preventing the 
vacuum from reaching appropriate levels for plasma generation.  Therefore, 
cleaning the vacuum chamber may be necessary.  Otherwise, skip step 1. 
 
1) Clean the vacuum chamber 
a) Carefully remove glass chamber from cleaner housing by first unscrew
stopper at the back of the unit. 
W
c) Dry and replace chamber
pump main switch is on. 
d) Turn on vacuum and pump dow
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e) Turn off vacuum and return to atmosphere.  The unit is now ready to be 
 only the side 
 
lly closed) and 
le glow coming from the 
t 
n). 
aminants that may affect cleaner 
s such as 
 for microfluidic chip generation because 
DMS will revert to its hydrophobic properties.  However, for use in the 
microa nt 
used as a cleaner. 
2) Make sure vacuum pump is attached to the plasma cleaner. 
3) Insert samples to be cleaned into the chamber.  Remember that
facing up will be cleaned, so using a simple sample holder is advantageous.
4) Turn on vacuum and pump down for 10-15 min. 
a) Hold chamber door in place (make sure release valve is fu
flip the red vacuum switch on (This is the switch above the door to the 
pump, not the switch on the plasma cleaner.) 
5) Generate and sustain plasma. 
a) Turn all switches on the plasma cleaner to the “On” position and turn the 
RF frequency to “High”. 
b) After about 10 seconds, you should see a purp
coil in the chamber.   
c) Begin to very slowly open the release valve so that the glow is brightest 
(magenta).   
d) Open and close this valve to maintain maximum plasma brightness for a
least 30 sec (I do 1 mi
6) Turn off all switches and slowly release air valve to return to atmosphere. 
7) Cover chamber to minimize cont
performance. 
 
Note:  Surface properties are only guaranteed to remain altered due to 
plasma cleaning for about 30 min, depending on environmental factor
humidity and air purity.  This is important
P
rray, only the glass surface is of concern and glass will maintain sufficie
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